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Abstract 
BACKGROUND 
Cardiac surgery patients have some of the highest reported incidence and prevalence of pressure 
injuries (PI). A growing subset of cardiac surgery include patients with end-stage heart failure who 
undergo ventricular assist device (VAD) or total artificial heart (TAH) surgery. The risk of PI and 
their natural history of development in this population are unknown and the specific risk factors 
for PI development remain unexplored. 
OBJECTIVES 
To perform a systematic review of the literature to identify the incidence and risk factors of PI 
development in patients undergoing VAD-TAH surgery and thereby inform study design and 
variables in an eight-year retrospective study of all patients undergoing VAD-TAH surgery at a 
large academic university medical center.   
METHODS 
The preferred reporting items for systematic reviews and meta-analyses or PRISMA statement 
guided this systematic review. Quality of evidence was determined using the Johns Hopkins 
Nursing Evidence-Based Practice Rating Scale. Two reviewers independently appraised 
manuscripts matching the eligibility criteria for study inclusion. Four databases including PubMed, 
CINAHL, Web of Science, Google Scholar, and hand searches of journals based on reference lists 
from included studies were utilized. Initial results of this primary search revealed zero studies that 
met inclusion and this search methodology was confirmed by medical librarian consultation. 
Therefore, a follow up retrospective study was necessary to identify incidence of PI in the VAD-
TAH population. However, a secondary search, dropping keywords of VAD-TAH and instead 
focusing on studies of on-pump cardiac surgery and mixed surgical studies where cardiac surgery 
patients were included, was conducted to establish variables to guide a retrospective study of all 
VAD-TAH surgeries between 2010-2018. The retrospective study evaluated the incidence of 
pressure ulcers by case, patient and incidence density for each of the respective 1000 patient days 
during the study period. Univariate statistics are reported by four different VAD-TAH devices. 
Variables significant in bivariate analysis were entered in a stepwise logistic regression model.  
RESULTS 
In the systematic review, 312 articles were identified from the databases with eight additional 
articles from hand searches. Following abstract review, 208 were excluded for not meeting 
inclusion criteria or study quality metrics. 77 articles were read in full, with 61 excluded, leaving 
16 articles for inclusion. 31 risk factors were identified for PI development in on-pump cardiac 
surgery patients with 11 risk factors which were identified as significant in multivariate analysis 
for inclusion in the retrospective study.  
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The final sample for investigation in the retrospective study included 292 independent VAD-
TAH surgical cases conducted in 265 patients. In total, 32 patients developed 45 PI. The 
incidence of PI per all surgical cases was 11% (32/292), with PI incidence per patient of 12% 
(32/265). Incidence density was found to be (10/1000) 1% for 2010-2012, (12/1000) 1.2% for 
2013-2015, and (10/920) 1.1% for 2016-2018 respectively. Logistic regression analysis revealed 
the following significant predictor variables for pressure injury in the VAD-TAH population: 
age, mechanical ventilation time and preoperative Braden Risk Assessment score.  
CONCLUSIONS 
The overall incidence of PI was much lower than anticipated given historical incidence of PI in 
non-device cardiac surgery patients. This population may be at higher risk of PI development 
due to: greater severity of illness preoperatively, longer operating room times, longer 
cardiopulmonary bypass time, and associated comorbidities, among others. However, given the 
low incidence of PI found in this study compared to historical comparisons of Coronary Artery 
Bypass Graft patients, a prospective study to further investigate significant risk factors and 
identify potential preventive mechanisms that decreased PI incidence in this population is 
warranted. 
  
RUNNING HEAD: VAD PRESSURE INJURIES 
7 
 
 
Manuscript #1 
Incidence and Predictor Variables of Pressure Injuries in Patients Undergoing Ventricular Assist 
Device and Total Artificial Heart Surgeries: A Systematic Review. 
 
 
C. Tod Brindle, PhD-C, MSN, RN, CWCN 
Doctoral Candidate, Virginia Commonwealth University School of Nursing 
 
Dr. Joyce Black, PhD, RN, CPSN, CWCN 
Professor, University of Nebraska School of Nursing 
 
 
Corresponding Author: 
C. Tod Brindle, PhD-C, MSN, RN, CWCN 
3550 Horizon Ct. 
Cumming, GA 30041 
Email: cbrindle@vcu.edu 
Phone: 614-595-1246 
 
  
RUNNING HEAD: VAD PRESSURE INJURIES 
8 
 
ABSTRACT 
BACKGROUND 
Cardiac surgery patients have some of the highest reported incidence and prevalence of pressure 
injuries (PI). A growing subset of cardiac surgery include patients with end-stage heart failure who 
undergo ventricular assist device (VAD) or total artificial heart (TAH) surgery. The risk of PI and 
their natural history of development in this population are unknown.  
OBJECTIVES 
To perform a systematic review of the literature to identify the prevalence, incidence, and risk 
factors of PI development in patients undergoing VAD-TAH surgery.  
METHODS 
The preferred reporting items for systematic reviews and meta-analyses or PRISMA statement 
guided this systematic review. Quality of evidence was determined using the Johns Hopkins 
Nursing Evidence-Based Practice Rating Scale. Two reviewers independently appraised 
manuscripts matching the eligibility criteria for study inclusion. Four databases including PubMed, 
CINAHL, Web of Science, Google Scholar, and hand searches of journals based on reference lists 
from included studies were utilized. Initial results of this primary search revealed zero studies that 
met inclusion and this search methodology was confirmed by medical librarian consultation. A 
secondary search dropping keywords of VAD-TAH and instead focusing on studies of on-pump 
cardiac surgery and mixed surgical studies where cardiac surgery patients were included was 
conducted.  
RESULTS 
312 articles were identified from the databases with eight additional articles from hand searches. 
Following abstract review, 208 were excluded for not meeting inclusion criteria or study quality 
metrics. 77 articles were read in full, with 61 excluded, leaving 16 articles for inclusion. 31 risk 
factors were identified for PI development in on-pump cardiac surgery patients with 11 risk factors 
being most commonly identified as significant in multivariate analysis across all studies.  
CONCLUSIONS 
The prevalence, incidence and natural history of PI in VAD-TAH patients remains unknown. This 
population may be at higher risk of PI development due to: greater severity of illness 
preoperatively, longer operating room times, longer cardiopulmonary bypass time, and associated 
comorbidities, among others. The results of risk factors associated with on-pump cardiac surgery 
patients will guide a subsequent 8-year retrospective study of the PI risk factors that potentially 
confront VAD-TAH patients, to gain more insight into PI development in this subset of the cardiac 
surgery population.  
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INTRODUCTION 
 Pressure ulcers are defined as, “localized injury to the skin and/or underlying tissue usually 
over a bony prominence, as a result of pressure, or pressure in combination with shear” 1. In 2016, 
the term pressure ulcer was revised to pressure injury by the National Pressure Ulcer Advisory 
Panel (NPUAP) and this term was defined as, “localized damage to the skin and underlying soft 
tissue usually over a bony prominence or related to a medical or other device. The injury occurs 
because of intense and/or prolonged pressure or pressure in combination with shear. The tolerance 
of soft tissue for pressure and shear may also be affected by microclimate, nutrition, perfusion, 
comorbid conditions and condition of the soft tissue”2. The revisions were made to attempt to more 
adequately reflect PI staging, particularly of Stage 1 and Deep Tissue Pressure Injury, as these 
pressure and shear related injuries do not always ulcerate.  
Globally, PI prevalence ranges from 27.3% to 72.5%. 1,3. In acute care settings, prevalence 
ranges from 0-49% contingent on the care setting and patient population. Over 2.5 million patients 
develop PI and cause 60,000 deaths in the United States per year 4. In the U.S., PI treatment costs 
may exceed $26.8 billion dollars annually 5, increase length of stay (LOS) by 11 days, and adds 
$30,000 to overall costs per admission. 6–9 Over 100 risk factors have been associated with the 
development of PI. Historically, cardiac surgery patients have been described as at high risk for PI 
development with incidence rates between 7-29.5%  10–17.  Risk factors for identification of PI in 
cardiac surgery patients remains a needed and clinically relevant area of research given the high 
incidence, cost, associated patient burden and lack of advancement in prevention of PI in cardiac 
surgery patients 18,19.  
Heart Failure and VAD-TAH Surgeries  
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A growing subset of the cardiac surgery patient population includes those with advancing heart 
failure (HF) who require implantable ventricular assist devices or a total artificial heart (VAD-
TAH).  In the U.S., the number of persons with HF is anticipated to exceed eight million people 
by 2030 and is projected to be the leading cause of disability 20.  One retrospective study in patients 
hospitalized with systolic HF investigated LOS, in-hospital mortality and associated predictors. 
Data were extrapolated from three payer based research databases 21. Of the 17,517 patients 
identified in the study, PI were present in 4% of subjects with associated increased LOS by 1.36 
days (p<0.0001) due to PI in every payer category (commercial 158/4109; Medicaid 76/2118; 
Medicare 446/11,370), evidencing a significant patient and economic burden. The use of VAD-
TAH devices is becoming the standard of care for both bridge-to-transplant and long-term 
destination therapy in end stage HF. Between 2009 and 2014, the percentage of heart transplant 
recipients who had a VAD at the time of transplant increased from 33.6% (n=631) to 44.9% 
(n=1018) 22. In an interrupted time series intervention study of 341 patients in two cardiac surgery 
intensive care units, the only statistically significant variable for PI development was heart failure 
(p=0.002) 15. Due to the high rate of PI in the cardiac surgery population, the impact of VAD-TAH 
surgery on PI development warrants investigation.  
Patients undergoing VAD-TAH procedures may be at greater risk for PI development 
compared to patients requiring a Coronary Artery Bypass Graft (CABG) procedure related to: 1) 
nature and length of the VAD-TAH procedure including cardiopulmonary bypass, 2) length of 
stay (LOS), and 3) physiological vulnerability and comorbidities of patients with advanced HF. 
The VAD-TAH procedure has greater surgical times than CABG (3-6 hours for CABG vs. 6-9 
hours VAD-TAH), plus higher total immobility, defined henceforth as the total time from 
preoperative admission in the perioperative suite to first turn in the intensive care unit post 
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operatively. Average LOS for CABG surgery is five days, while VAD and TAH average LOS is 
20 and 18 days, respectively (Cotts et al., 2014; 24. Finally, patients who need VAD-TAH have 
advanced heart failure with severely reduced cardiac function, whereas patients who undergo 
CABG have coronary artery occlusion with or without existing heart failure. This differentiation 
is significant. Patients with advanced left ventricular failure or biventricular failure requiring 
VAD-TAH have higher preoperative American Society of Anesthesia (ASA) scale scores 
compared to patients having CABG. ASA scale scores range from I (mild systemic disease) to V 
(moribund patient not expected to survive without surgical intervention 25. ASA scores greater 
than or equal to three are associated with higher operating room PI rates 26.  Fred and colleagues 
(2012) reported that for each one-point increase in ASA, the odds of developing PI increased by 
149% in a sample of 138 surgical patient from mixed specialties in a retrospective review.  
CARDIOPULMONARY BYPASS 
Cardiopulmonary bypass (CPB) creates a non-pulsatile, bloodless surgical field while 
reintroducing  oxygenated blood back into the systemic circulation 27. Use of CPB is associated 
with multisystem organ dysfunction including cardiac, pulmonary, renal, hepatic, gastric and 
cerebral failure. The severity and extent of organ failure depends on the duration of: CPB, surgery, 
aortic cross clamping and plasma lactate levels 28. A systematic review of 23 studies with a total 
sample size of 7,976 patients identified that on-pump cardiac surgery patients had significantly 
higher incidence of stroke, renal failure, ventilation time and sternal infection 29. Systemic 
inflammation and subsequent organ and tissue damage is further complicated by the non-pulsatile 
nature of blood flow associated with CPB. Systemic changes associated with CPB include a severe 
systemic inflammatory response syndrome caused by activation of both cellular and solid proteins 
27 as described in TABLE 1. Alterations to vascular permeability and tissue edema is most 
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profound in patients undergoing CPB for 80 minutes or longer 30. Despite the focus of much 
research on injury to body organs from CBP, the effect of CPB on the skin has not been reported. 
Given the high prevalence of PI associated with CABG procedure and the additional 
vulnerability associated with advanced HF and VAD-TAH surgical procedures, it is hypothesized 
that the VAD-TAH surgery represents the highest level of risk for PI development among cardiac 
surgery patients. However, the actual incidence is unknown and represents a large gap in our 
current understanding of PI etiology in this population.   
Therefore, the aim of this systematic review of the literature is to describe the prevalence, 
incidence and risk factors associated with PI development in heart failure patients undergoing 
ventricular assist device or total artificial heart (VAD-TAH) surgery.    
METHODS 
The design for systematic review of the literature utilized the methods described in the preferred 
reporting items for systematic reviews or PRISMA statement 35. Strength and quality of evidence 
was determined using the Johns Hopkins Nursing Evidence-Based Practice Rating Scale seen in 
Figure 1 36. Risk of bias associated with the identified studies was determined using the Cochrane 
tool for assessing risk of bias 37.  
Inclusion criteria for the systematic review involved studies reporting the development of 
PIs in cardiac surgery patients undergoing VAD or TAH surgery. Specifically, retrospective or 
prospective observational studies reporting study incidence or prevalence of pressure injuries 
within the perioperative, intraoperative or immediate postoperative period were considered. Study 
characteristics including English only language and a timeframe of 1966-2017 to coincide with the 
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first reported implantation of a mechanical support device for myocardial recovery after heart 
surgery 38.  
Informational sources utilized for study identification and inclusion included PubMed, 
CINAHL, Web of Science, Google Scholar, and hand searches of journals based on reference lists 
from included studies. Two search strings of keywords utilized for PubMed and CINAHL 
databases including associated filters are show in Figure 2. For these initial searches, 240 articles 
were found, 30 were selected after abstract review, however after full text review, 0 articles were 
identified that included VAD or TAH patients which reported on PI risk factors, incidence, 
prevalence or natural history within these patients. The results were validated by the inclusion of 
a medical librarian who confirmed via independent search the inability to identify any articles 
matching the eligibility criteria for this systematic review.  
Secondary Review 
Therefore, a secondary search was conducted removing keywords specific to ventricular 
assist device and total artificial heart and focusing on on-pump cardiac surgical procedures. The 
same databases were utilized. The search included a revision to the eligibility criteria which 
included only studies from 2007 to the present. This decision follows the changes to the National 
Pressure Ulcer Advisory Panel’s updated pressure ulcer staging system 39 which included the 
addition of suspected deep tissue injury and unstageable pressure ulcer classifications. Further, the 
time frame is justified as the morbidity of cardiac surgical patients is considerably different in the 
last 10 years than during the historical period between 1966-2007. Further inclusion criteria 
allowed, 1) all retrospective or prospective studies including patients undergoing on-pump (e.g. 
use of cardiopulmonary bypass during cardiac surgery) cardiac surgery procedures or 2) reported 
systematic reviews and meta-analyses of cardiac surgery patients and 3) studies of intraoperative 
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PI risk where cardiovascular surgery patients were part of the sample. Grey literature was 
evaluated and included if such sources described research studies with sufficient methodological 
description to determine strength of evidence and quality. Articles that were strength of evidence 
lower than III and/or quality scores of C or less were excluded. Similarly, articles were not included 
if designated as off-pump cardiac surgery or vascular/thoracic procedures. Duplicates and 
reprinted publications were removed to reduce the risk of transverse and longitudinal bias. A flow 
diagram of study records identified can be found in Figure 3. Search data and identified study 
records were managed with Excel spreadsheet software in chronological order with the authors 
(TB & JB) reviewing each full text article independently for inclusion, strength of evidence and 
quality, as well as risk of bias.  Following review, these records were extrapolated to the evidence 
table shown in Table 1.   
On-pump cardiac surgery with CPB cannot be compared to other non-cardiac surgeries due 
to the differences in perioperative, operative and postoperative patient characteristics 32. Therefore, 
articles including off-pump cardiac surgery, or beating heart surgery, were removed secondary to 
the CPB research indicating that off-pump patients are at considerably less risk for complications 
including multisystem organ failure 33. Since off-pump surgical technique was developed in the 
mid-1990s, it was assumed any articles that did not differentiate on-versus-off pump CABG were 
on-pump, given reports that the use of off-pump technique was negligible in 1995, about 10% in 
1999 and estimated to be around 50% by 2005 40.   
RESULTS 
ON-PUMP CARDIAC SURGERY STUDIES 
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 Based on the outcomes of the VAD-TAH review as described above, the secondary aim of 
this systematic review was to identify articles involving on-pump cardiac surgery patients that 
represent the closest surrogate for the VAD-TAH population.  In total, 312 articles were identified 
from the respective databases with eight additional articles identified by hand searches. Following 
abstract review, 208 were excluded for not meeting the appropriate surgical type, procedure, date 
range or study quality metrics. Seventy-seven articles were reviewed, with 60 excluded secondary 
to: reprints, non-English language, being off-pump populations, vascular or thoracic procedures 
and poor strength of evidence and quality scores. An evidence table of all 17 included articles is 
provided in TABLE 2. Seven articles included studies involving cardiac surgery patients only, 
whereas nine included mixed surgical populations in addition to ICU and operating room locations. 
Common risk factors found between the respective studies who performed multivariate analysis 
are found in TABLE 3.  
Cardiac Surgery Population 
 Feuchtinger and colleagues (2007) identified that 33/53 consecutively enrolled CABG 
patients developed 47% of ulcers on post-operative day 0 and 15% of the remaining pressure 
injuries between day 1 and day 7 after surgery. The primary limitation of this study was the high 
rate of attrition as patients were dropped from the study after they left the ICU. The primary 
purpose of this study was to compare post-operative risk assessment scores or predict PI 
development using the Norton, Water low and Braden Risk Assessment Tools. The Braden score 
was found to be most appropriate for the CABG population given its superior sensitivity (78%) 
and specificity (29%) at a cut-off point of 16. Remaining scores indicated that patients should all 
be considered as at risk for the first five postoperative days.  
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 A unique consideration after CABG surgery includes the impact of mental health on the 
post-operative complications. In a study of 135,701 CABG surgeries in the New York state 
database, patients with mental disorders (schizophrenia, major depression, dementia, bipolar 
disorder, and other psychiatric conditions) were found to have higher rates of PI than those without 
mental disorders (7.3/1000 vs. 1.8/1000; AOR 1.42, p=.006) (Li, Glance, Cai, & Mikael, 2008). 
Additionally, the effect of mental health disorders on patient safety varied widely between 
hospitals suggesting different facilities are not as adept as others to care for patients with mental 
disorders. In this study, the adjusted odds ratio (OR 1.32; p<0.01) suggest that having a psychiatric 
disorder alone increases the risk of complication following CABG.  
 In a prospective longitudinal study of 100 cardiac surgery patients in Spain, 18% of patients 
developed PI, yet no statistically significant variables were found to differentiate the PI and non-
PI groups.42 No relationship between the duration of surgery, cardiopulmonary bypass time, blood 
pressure or hypothermia and development of a PI was reported by the researchers.  
 A descriptive cross-sectional study of 333 patients in Iran 43 identified a 21.3% (n=71) PI 
incidence rate. Of these, 94% were identified immediately after the procedure, within the first 24 
hours in ICU or after transferring to the general floor. Risk factors associated with PI development 
in multivariate analysis included age, gender, hypertension, myocardial infarction, intraoperative 
hypoxemia, not having a specialty mattress post operatively, blood pressure sustained less than 
80mmHg systolic, requiring reoperation, low hematocrit, low albumin and increased length of 
hospital stay leading to increased PI risk.  
 In a study of 286 adult and pediatric cardiac surgery patients from China, the PI incidence 
rate in adults was 18.8%, with significant predictors of corticosteroid administration (p<0.05) and 
length of surgery (p=0.03)44. The authors’ stated that cardiopulmonary bypass, gender, weight, 
RUNNING HEAD: VAD PRESSURE INJURIES 
17 
 
intraoperative and post-operative vasoactive medications were not significant predictors of PI risk. 
In a separate prospective consecutive cohort study of 149 patients in a cardiac ICU in China 45, a 
24.8% incidence rate of PI development was reported with 94.6% of identified as stage 1 and the 
remainder (5.4%) stage 2.  Logistic regression indicated that valvular disease (OR 6.43, 95% CI 
1.44, 28.69; p=0.063) coronary artery disease (OR 8.8, 95% CI 1.74, 44.62; p<0.03), weight (OR 
0.971, 95%CI 0.94-1.004; p<0.084) and surgery duration (OR 1.005, 95%CI 1.000-1.010; 
p<0.036) were the major risk factors for ulceration. A primary limitation of this study was the 
author’s use of the 2007 National Pressure Ulcer Advisory Panel (NPUAP) pressure ulcer staging 
definitions, yet inclusion of only Stages 1-4 PI as their method of classification. Therefore, it is 
possible that the high rate of reported stage 1 pressure injuries reflects the misclassification of deep 
tissue pressure injuries (DTPI).  
 Robich and colleagues investigated rates and risks associated with “never events” using 
the National Inpatient Database (NIS) between 2003 and 2011 for all patients undergoing adult 
cardiac operations, specifically looking at CABG, valve surgeries, and thoracic aneurysm repair 
46. The study included 588,417 patients among whom 4377 “never events” were reported. PI rates 
were reported as 4% over the entire study period, however, this number likely reflects historical 
bias as rates were reported as 0% between 2003-2007 and 12% between 2008-2011. The Centers 
for Medicare and Medicaid Services (CMS) decision to no longer reimburse hospitals for hospital 
acquired conditions such as PIs at a higher diagnostic category on October 1, 2008, likely resulted 
in the high rate of change between these two-time periods. However, the study did determine that 
cardiac surgery patients who experience a never event were at an increased risk of morality (OR 
2.63, 95% CI 2.16-3.2, p<0.001), length of stay (MR 2.03, 95%CI 1.98-2.09, p<0.001) and total 
hospital charges (MR 1.73, 95% CI 1.68-1.78; p<0.001).  
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Mixed Surgical Population 
 Mixed surgical patient studies were considered to identify other potential risk factors but 
adds selection bias due to variance in underlying comorbid states, operative body position and the 
lack of CPB for non-cardiac patients. Liu and associates (2012) performed a meta-analysis of six 
studies (4 cardiac surgery, 2 mixed surgical populations) of 2453 to investigate the effect of 
diabetes mellitus (DM) on the development of PIs during surgical procedures. The incidence rate 
across studies was 11.8%, with no significant heterogeneity (X25 =1.98, p=0.85, I
2=0%) between 
the studies. All studies were listed as IIB evidence and 7/8 for quality according to the Newcastle-
Ottawa scale. The meta-analysis revealed that DM was significantly associated with the 
development of PI (OR 2.15 (95%CI: 1.62-2.84; Z-5.32, p<0.00001, fixed effects model 
OR=2.13). Even after the removal of one retrospective study, the odds ratio was still significant 
(OR=2.03) 47. These findings were supported by a second meta-analysis of 13 studies including 
total comparison groups of patients with PI (n=2367) and patients without (n=12053) showing DM 
to be a significant risk factor across surgical types with a pooled odds ratio of 1.74 (95%CI= 1.40-
2.15, I2=51.1%) 48. When isolating the four studies involving cardiac surgery patients alone, DM 
remained a significant risk factor (OR=2.0, 95%CI=1.42-2.82, I2= 0%). Importantly the authors 
identified an additional consideration in the cardiac surgery population to be limited movement 
associated with IABP and VAD devices, however these interventions modalities were not 
evaluated in the statistical model.  
 A systematic review of the literature by Rao and colleagues (2016) reviewed 12 studies 
looking at critical care, surgical ICU or cardiac surgery ICU for preoperative risks of PI 
development. The authors described significant risk factors according to preoperative, 
intraoperative and postoperative findings. The highest odds for PI development included spinal 
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cord injury (OR 16.8), history of previous PI (OR 13.51), and hemodialysis within 24 and 48 hours 
of surgery (OR= 4.77; 9.43 respectively), DM (OR=2.70), fecal incontinence (OR 3.27) limited 
mobility (4.42), and mechanical ventilation (OR=4.82) The researchers highlighted the relative 
absence of DTPI in the studies in this review and suggested that “hypoxic reperfusion” is linked 
to DTPI and has not been sufficiently included in previous frameworks of PI development. Articles 
addressing DTPI include a 5 year retrospective study of 119 patients in a seven surgical ICUs 49. 
The authors found that for every hour the patient spent in surgery, the risk of DTPI increased by 
20%. Other significant variables included dialysis (OR 4.0, 95%CI 06-0.99, p=0.05), 
cardiogenic/septic shock (OR=10, 95%CI 0.025-0.43, p=0.002), low diastolic blood pressure (OR 
0.93, 95%CI 0.88-0.99, p=0.02) and time of surgery in hours (OR 1.20, 95% 1.07-1.33, p=0.001). 
Cox and Roche (2015) identified an incidence of 13% (41/306) in a retrospective correlational 
study of 306 patients in a medical surgical and cardiac surgical ICU 50. Of these pressure injuries, 
39% were DTPI and 56% were found on the sacrum. The authors identified significant risk factors 
for PI development included longer infusion times of: vasopressin (32 hours vs 87 hours, p=0.005), 
high dose vasopressin (20 hours vs. 57 hours, p=0.03) and patients receiving both vasopressin and 
norepinephrine (X2=39.3, p<0.001). Vasopressin was the only vasoactive medication to emerge as 
a significant predictor in multivariate analysis. The authors commented that the dose of 0.03 U/min 
at longer infusion times may be a tipping point for pressure injury development.  
A retrospective matched case-control study of 32,963 patients from a level-one trauma 
center in the US investigated the time in the operating room as a risk factor for PI.51 In this study 
there was an overall 2.8% incidence rate and time in surgery was identified as a significant risk 
with increasing odds over time (<2 hours OR=1.1; 2-4 hours OR=1.2; 4-6 hours OR= 1.6; >6 hours 
OR 6.4). Additionally, documentation of PI occurrence 72 hours after surgery was found in 78% 
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of patients, with only 4.5% present within the first 24 hours, suggesting an extended assessment 
period after surgery is necessary for PI identification 52. A prospective convenience sample of 258 
patients undergoing operations of 3 hours or more (21/258 cardiac; 69/258 general surgery) found 
a PI incidence rate of 8.1% overall 53. Significant risk factors identified in logistic regression 
included use of specific Operating Room table pads: foam pad (OR=14.740), OR table with Foam 
pad and valve (OR=3.397), use of gel pad on the OR table (OR=2.809), use of the Jackson table 
(OR 2.231) and preoperative patient temperature (OR 1.014). Of those patients who developed PI, 
33.7% of the PI group had ASA scores of 2, while 53.5% had ASA scores of 3. The use of ASA 
scores to identify risk is further supported by a retrospective secondary analysis of 2695 patients 
from cardiovascular, burn and surgical ICUs reported a 10% PI incidence rate and identified ASA 
score of 4 or 5 26 as a significant predictor of PI development. Propensity matching of 122 cases 
identified a significant intraoperative risk factor to be receipt of blood products (OR 1.71, 95%CI, 
1.03-2.84, p=0.04). 
DISCUSSION 
The cardiac surgery population has historically been identified with  intraoperative PI incidence 
rates as high as 29.5%, 11,54. Subsequent prospective cohort studies of subpopulations such as 
cardiac surgery bypass grafting (CABG), the most commonly studied cardiac surgical intervention, 
have shown incidence rates as high as 53.4% in the cardiac ICU 55 yet the actual incidence and 
prevalence is still unknown. One of the greatest limitations of available literature reviews and 
research in the cardiac surgery population is the preponderance of these earlier studies occurring 
prior to the description and recognition of deep tissue pressure injuries (DTPI) (Black, Brindle, & 
Honaker, 2016). Review of articles prior to inclusion of DTPI in National Pressure Ulcer Advisory 
Panel Guidelines in 2007 39 would lead to historical bias. For example, three studies commented 
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on “violet pressure ulcer” (Feuchtinger et al., 2005), ecchymosis as a risk factor for PI 14 and in 
Schoonhoven and colleagues’ study, 34 patients were excluded due to symptoms that were not 
common to known PI staging classifications systems at the time 16. The authors described, “painful 
or numb discoloration that disappeared (partially) when light pressure was applied; sharply 
defined; indurated; lasting 13-21 days despite relief of pressure, and/or bright red discoloration.” 
(p.169). These inconsistencies in assessment likely led to misclassification of many post-operative 
PI prior to 2007 given the high rate of reported stage 1 and stage 2 PI in these early studies. 
Additionally, an important consideration that is not addressed in the studies regarding PI 
etiology to date is the distinction between pulsatile versus non-pulsatile blood flow both during 
CPB intraoperatively and during the use of VAD devices in the postoperative period. 
Intraoperatively, non-pulsatile blood flow, theoretically, may not provide sufficient intravascular 
pressure to open the dermal capillary sphincters, possibly impacting cutaneous vascularization. 
Moreover, during CPB, the impact of volumetric dilution of the circulating serum on perfusion of 
the cutaneous complex is not well understood. Contrasting the concern over pulseless blood flow 
during CPB, is the understanding that patients with VAD devices who are ambulatory after 
surgery, do not have spontaneous cutaneous vascular collapse despite being on an ongoing 
pulseless flow device.  
Animal research investigating the concerns over end organ perfusion between pulsatile and 
non-pulsatile circulation has been described. A porcine study of 20 pigs randomized to 4 groups 
(pulseless and pulsatile groups at two different pressure settings evaluated within the renal artery) 
were evaluated for impact of perfusion on renal recovery following normothermic ischemia 57. In 
the high pressure pulseless and pulsatile groups (renal artery pressure 65 ± 1.6 mmHg) no 
differences were seen in renal recovery. However, in the lower pressure groups (40 ± 1.1 mmHg) 
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there was a significant difference in recovery of renal blood flow, ATP recovery and VO2, with 
pulsatile perfusion being superior to pulseless perfusion in all outcomes. Further, results indicated 
no difference in renal histology between the pulseless or pulsatile groups. A later study reported 
the impact of end-organ function during chronic non-pulsatile circulation using an animal model 
of 15 sheep allocated to LVAD or control group which were sacrificed electively at 30, 90, 180 
and 340 days for evaluation 58. The researchers report that there were no histologic differences 
between organs of pulsatile and non-pulsatile animals, no significant difference in mean blood 
pressure, however significantly elevated plasma renin levels in pulseless animals was found. Feng 
and colleagues evaluated the short-term effects of completely non-pulsatile versus pulsatile 
circulation on peripheral vascular permeability of 10 calves with continuous flow Heartmate III 
rotary pumps 59. Five calves had their pump speeds modulated to result in a low frequency pulse 
pressure of 10-25mmhg (physiologic range) at 40 pulses a minute, while the remaining five had 
non-pulsatile systemic circulation. Researchers assessed skeletal muscle biopsies at postoperative 
days 1, 7 and 14 with additional comparisons of tissue water content, morphologic alterations and 
comparisons of immunohistochemistry in respective biopsies. Results indicated no significant 
differences in tissue water content, or skeletal muscle morphology at any postoperative time point. 
There were no significant differences in the expression or distribution of study 
immunohistochemical biomarkers between the groups causing researchers to observe no 
peripheral endothelial injury or peripheral microvascular permeability in either group. These 
animal studies, therefore, raise the question as to whether pulseless blood flow alone is a risk factor 
for PI development or is systemic inflammatory response associated with total CBP time more 
associated with downstream impact to end tissue perfusion? 
LIMITATIONS 
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First, as there were no articles identified in the literature for VAD-TAH surgery patients 
and PI, there is inherent risk of selection bias in the creation of the secondary search string as the 
author attempted to select a surgical population that approximated the risks associated with VAD-
TAH procedures, namely, on-pump cardiac surgery.  
There is considerable probability that many Stage 1 PI and stage 2 PI reported in these 
studies were actually deep tissue injury, which greatly changes the severity of the injury itself. 
This fact was highlighted in the study by Cox and Roche (2015) as their results contrasted historical 
outcomes with 39% of the observed pressure injuries being DTPI with 56% of them found on the 
sacrum. Another possible explanation for this difference in reported severity may be the overall 
morbidity of patients and advanced, life-prolonging intensive care management in 2017 versus the 
studies of the early 1990s. 
CONCLUSION  
The incidence and natural history of PI development in the VAD and TAH cardiac surgery 
patient remains unknown. This finding represents a significant gap in our understanding of 
pressure injury etiology and prevention warranting on-going research. Additionally, a systematic 
review of 1533 articles failed to identify studies specifically investigating interventions for PI 
prevention in the cardiac surgery population 60.  This gap in existing evidence does little to reduce 
the risk and rate of PI in cardiac surgery patients 54 and highlights the critical need to identify risk 
factors leading to PI development to guide prevention in the cardiac surgery population. The 
systematic review reported here will guide the first, 8-year retrospective analysis of VAD and TAH 
patients to identify incidence, and predictors of PI development in a large academic university 
health center in the United States.  
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FIGURE 1. John’s Hopkins Nursing Evidence-based Practice Rating Scale 
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FIGURE 2. Search Strategy for Systematic Review of VAD-TAH Patients 
VAD-TAH String 1 
((((((("Heart Failure"[Mesh] OR Heart Failure[TIAB]))) OR (("Cardiovascular Surgical 
Procedures"[Mesh] OR Cardiovascular Surgical Procedure*[TIAB]))) OR (((((((Vascular Assist 
Device*[TIAB] OR Artificial Ventricle*[TIAB] OR Heart Assist Pump*[TIAB] OR Heart Assist 
Device*[TIAB] OR Ventricular Assist Device*[TIAB] OR Artificial Heart Ventricle*[TIAB] OR 
Artificial Heart*[TIAB]))) OR ((((("Heart, Artificial"[Mesh]) OR Artificial Heart[TIAB]))) OR 
((Implantable Device*[TIAB]) AND (Heart patient*[TIAB] OR Cardiac Patient*[TIAB])))) OR 
(("Heart-Assist Devices"[Mesh] OR "Heart, Artificial"[Mesh]))) OR (((Device*[TIAB])) AND 
((Heart Lung Bypass*[TIAB] OR Cardiopulmonary Bypass*[TIAB])))) OR "Cardiopulmonary 
Bypass"[Mesh]))) AND ((("Pressure/adverse effects"[Mesh]) OR Deep Tissue Injur*[TIAB]) OR 
(("Pressure Ulcer"[Mesh] OR Pressure Ulcer*[TIAB] OR Bedsore*[TIAB] OR Pressure 
Sore*[TIAB] OR Decubitus Ulcer*[TIAB] OR Bed Sore*[TIAB]))) Filters: English 
 
VAD-TAH String 2 
((((((("Heart Failure"[Mesh] OR Heart Failure[TIAB]))) OR (("Cardiovascular Surgical 
Procedures"[Mesh] OR Cardiovascular Surgical OR “Operating Room” OR “Operating Theatre” 
OR “Intraoperative” OR Procedure*[TIAB]))) OR (((((((Vascular Assist Device*[TIAB] OR 
Artificial Ventricle*[TIAB] OR Heart Assist Pump*[TIAB] OR Heart Assist Device*[TIAB] OR 
Ventricular Assist Device*[TIAB] OR Artificial Heart Ventricle*[TIAB] OR Artificial 
Heart*[TIAB]))) OR ((((("Heart, Artificial"[Mesh]) OR Artificial Heart[TIAB]))) OR 
((Implantable Device*[TIAB]) AND (Heart patient*[TIAB] OR Cardiac Patient*[TIAB])))) OR 
(("Heart-Assist Devices"[Mesh] OR "Heart, Artificial"[Mesh]))) OR (((Device*[TIAB])) AND 
((Heart Lung Bypass*[TIAB] OR Cardiopulmonary Bypass*[TIAB])))) OR "Cardiopulmonary 
Bypass"[Mesh]))) AND ((("Pressure/adverse effects"[Mesh]) OR Deep Tissue Injur*[TIAB]) OR 
(("Pressure Ulcer"[Mesh] OR Pressure Ulcer*[TIAB] OR Bedsore*[TIAB] OR Pressure 
Sore*[TIAB] OR Decubitus Ulcer*[TIAB] OR Bed Sore*[TIAB])))  
 
CARDIAC SURG, NO-DEVICE 1 
((((((("Heart Failure"[Mesh] OR Heart Failure[TIAB]))) OR (("Cardiovascular Surgical 
Procedures"[Mesh] OR Surgery OR Cardiovascular Surgical Procedure*[TIAB]))) AND 
Intraoperative AND (Heart patient*[TIAB] OR Cardiac Patient*[TIAB])))) OR ((Heart Lung 
Bypass*[TIAB] OR “on-pump” [TIAB] OR Cardiopulmonary Bypass*[TIAB])))) OR 
"Cardiopulmonary Bypass"[Mesh]))) AND ((("Pressure/adverse effects"[Mesh]) OR Deep Tissue 
Injur*[TIAB]) OR (("Pressure Ulcer"[Mesh] OR Pressure Ulcer*[TIAB] OR Bedsore*[TIAB] OR 
Pressure Sore*[TIAB] OR Decubitus Ulcer*[TIAB] OR Bed Sore*[TIAB]))) Filters: English 
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FIGURE 3. Flow Diagram of Systematic Review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
312 Records from Data Base 
Searches: 
• PubMed: 159 
• CINAHL: 17 
• Web of Science: 51 
• Google Scholar: 77 
 
8 Records from Other Sources: 
• Hand Search Journal of 
Cardiac Surgery: 4 
• Hand Searches from 
Records: 4 
 
285 Records after Duplicates Removed 
285 Records Screen by Abstract 208 Records Excluded 
77 Full Text Articles Assessed for 
Eligibility 
 
60 Articles Excluded Due to: 
• Reprints 
• Non-English Language 
• Off-Pump Cardiac Surgery 
Procedures 
• Vascular/Thoracic 
populations 
• Poor SOE and Quality Scores 
• Case Study/Case Series 
17 Studies Included for Review 
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TABLE 1: Cardiopulmonary Bypass Systemic Inflammatory Response 
Inflammatory Response Secondary to CPB Author 
Activation of complement secondary to contact with CPB circuits and formation of 
anaphylatoxins and terminal membrane attack complex (C5b-C9).  
Esper, et al 2014; Murphy 
& Angelini, 2004;  
Autonomic regulation of peripheral and myocardial arterioles; decreased peripheral 
vascular resistance on separation from CPB. 
Ruel, et al 2004; Song et 
al, 2017. 
Neutrophil activation from anaphylatoxins and kallikreins causing lytic enzyme release 
and reactive oxygen species.  
Ruel, et al 2004; Murphy 
& Angelini, 2004; Esper et 
al, 2014;  
Cytokine activation increasing inflammation and ROS response and endotoxin production. Esper, et al 2014;  
Metabolic derangement of hyperglycemia, hyperinsulinemia and insulin resistance. Ruel et al, 2004; Esper, et 
al 2014;  
Profibrinolytic state: elevated tissue plasminogen activator (tPA) Esper, et al 2014;  
Hemodilution leading to decreased oxygen carrying capacity and tissue ischemia.  Wan, et al 2002; Esper et 
al, 2014;  
Ischemia Reperfusion Injury: intracellular calcium trapping, reactive oxygen species and 
neutrophil-endothelium interactions. Causes access synthesis of superoxides, hydroxyl 
radicals and peroxynitrate free radicals.  
Ruel et al, 2004; Wan et al, 
2002;  
Embolic events: gaseous, lipoproteins and particulate.  Murphy & Angelini, 2004 
Leukocyte Production: causes neutrophil rolling, adherence and transmigration with 
increased lifespan. Leads to infiltration.  
Murphy & Angelini, 2004; 
Ruel et al, 2004;  
Cyclooxygenase and constrictive prostaglandin release Ruel, et al 2004;  
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TABLE 2: Evidence Table  
Study 
Author 
Design Strength 
of 
Evidence 
& 
Quality 
Sample/Setting Study Aim PI Incidence 
& 
Prevalence 
Predictors by 
Multivariate 
Analysis 
Limitations  
Feuchtinger, 
Halfens & 
Dassen, 
2007 
Prospective 
Observational, 
Convenience 
Sample 
III B 53 Cardiac 
surgery patients  
(Germany)  
 
ICU Daily 
Assessment x4 
days 
To appraise 
risk 
assessment 
using a 
standardized 
instrument.  
49%- 26/53 
on POD 0 
2 on POD 1 
4 on POD 2 
1 on POD 3 
0 on POD 4 
1 on POD 7 
 
33 or 34 PI in 
this study… 
thought 33 
from the text. 
No multivariate 
analysis. 
 
Sensitivity/Specificity 
and design of Braden 
found to best fit CT 
Surgery population. 
Attrition each day 
(total patients) 
POD1=53, 
POD2=36, 
POD3=20, POD4=17  
Li, et al 
2008 
Retrospective 
Mental 
Disorder & 
Complications 
after CABG  
III A N=135,701 
CABG in NY 
State Database 
(US)  
 
OR/ICU/Ward 
Compare 
occurrence of 
postoperative 
complication 
in patients 
with and 
without 
PI w/Mental 
Disorder 
7.3/1000; 
without 
1.8/1000 
Decubitus ulcer AOR 
1.42 (95%CI 1.10-
1.82) p=0.006 
 
Effect of mental 
disorders on safety 
 
Authors suggest 
differing ability to 
care for psychiatric 
pts was hospital site 
dependent. 
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mental 
disorders who 
underwent 
CABG 
surgery in 
NY.  
outcomes varied 
across hospitals 
(variance of random 
coefficients 0.16, 
SE=0.07 for overall 
complication; 0.79 
SE=0.35 for PI.  
OR 1.32 (p<0.01) for 
psychiatric disorder 
alone having 
increased risk 
complication.  
 
 
 
 
Mental disorders 
included: 
schizophrenia, major 
depression, bipolar, 
dementia, and other 
mental disorders by 
ICD-9 code.  
Ginés, et al 
2009 
Prospective 
Longitudinal  
III B 100 CT Surg 
(Spain) 
 
OR 
 18% (18 pts 
developed 22 
PI) 10% had 
PI Stg 1 on 
arrival to OR.  
No statistically sig 
variables found 
between PI and no PI 
group 
No relationship of PI 
to duration of 
surgery, 
cardiopulmonary 
bypass time, BP or 
hypothermia. 
Primiano, et 
al, 2011 
Prospective 
observational, 
convenience 
sample 
III B 258 patients 
with OR >3 
hrs. 
 
Identify 
prevalence of 
and risk 
factors 
associated 
with PI 
formation in 
21/258 
(8.1%) 
Logistic regression: 
Foam Pad 
(OR=14.74) 
Gel Pad (OR=2.809) 
 
ASA 2 (33.7% of PI) 
ASA 3 ((53.5%) 
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Cardiothoracic 
21/258  
 
General 69/258 
the OR in 
patients 
undergoing 
surgery >3 hr. 
Jackson Table 
(OR=2.231) 
Preop Temperature 
(1.014) 
No significance: 
Type anesthesia, 
surgery, Surgery 
Length, intraop 
hypotension/hypoxia, 
not sig.  
 
Ghavidel et 
al, 2012 
 
Descriptive 
Cross-
Sectional 
III B 333 Patients 
(Iran)  
 
Cardiac 
Surgery OR 
and ICU 
 21.3% (71 PI, 
67 in ICU, 4 
after transfer 
ward).  
Age, sex, HTN, MI, 
intraop hypoxemia, 
mattress, post op 
inotropes, BP 
<80mmhg, 
reoperation, low 
HCT, LOS, Low 
Albumin 
All significant in LR? 
Most (what is the 
n/%) PI found 
immediately after 
OR within first 24 
hours of ICU. 
Liu, He, & 
Chen, 2012 
Meta-analysis IA N=2453 
(5 US, 1 
Belgium)  
 
6 Studies all 
listed as 2B 
evidence.  
 
4/6 were 
cardiac surgery 
Aim of meta-
analysis was 
to review 
evidence 
related to 
association 
between DM 
and surgery 
related PI. 
11/8% 
290/2453 
No sig 
heterogenicity 
(X25 =1.98, 
p=0.85, 
I2=0%)across 
studies 
DM OR 2.15 
(95%CI: 1.62-2.84; 
Z-5.32, p<0.00001)  
Fixed effects model 
DM OR 2.13 
Removal of 1 Retro 
study OR 2.03 (for 
risk factor DM?) 
 
 
 
 
No evidence of 
publication bias. 
All studies scored 
7/8 on Newcastle-
Ottawa scale for 
quality (what kind of 
quality?). 
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or included 
cardiac 
 
 
O’Brien, et 
al 2013 
Retrospective 
Secondary 
Analysis  
III A 2,695 patients 
from 3 ICUs 
 
Surgical ICU 
Burn ICU 
Cardiovascular 
ICU  
 
Merged 
datasets from 
Talsma et al 
and intraop 
database. 
Hypothesized 
intraoperative 
risk factors 
increased 
likelihood of 
postoperative 
new-onset PI. 
Retrospective 
review to 
characterize 
intraoperative 
risk factors 
associated 
with 
development 
of PI.  
10.7% 
(288/2695) 
 
 
Independent 
predictors: ASA score 
4 or 5; Underweight 
BMI, noncardiac 
operation, history of 
CHF, renal disease, 
existing airway prior 
to OR 
9.7% stg 2, 0.8% stg 
3, 0.4% stg 4, 23, 
0.9% DTI 3.3% US.  
 
Propensity matching 
of 122 cases:  
Intra-operative blood 
products (OR 1.71, 
95S%CI, 1.03-2.84, 
p-0.04);  
Pts. With PI: 60 
minutes longer OR 
time(non-significant 
finding) 
 
Ettema et al, 
2013 
Systematic 
Review of Lit 
(PRISMA) 
III A 23 Studies 
(strict 
Inclusion) 
 
 All studies B- 
to A+ Quality 
Score 
To provide an 
overview of 
both single 
and multi-
component 
preadmission 
interventions 
designed to 
prevent single 
No studies 
Identified that 
described PI 
prevention.  
NA 
No studies with PI as 
outcome variable 
Authors conclude no 
high-quality 
evidence to prevent 
PI to date. 
RUNNING HEAD: VAD PRESSURE INJURIES 
41 
 
and multiple 
postoperative 
complications 
in older 
cardiac 
surgery 
patients. 
Hayes, et al, 
2015 
Retrospective, 
matched case-
control. 
III A 32,963 patients  
(Vanderbilt, 
USA)  
 
OR, ICU 
To determine 
if time in the 
operating 
room 
increases risk 
of newly 
documented 
PI. 
 
 
 
931/32,963 
(2.8%) 
OR for PI 
development and OR 
time: 
1.1 <2hrs 
1.2 >2, <4 
1.6 >4, <6 
6.4 >6 
 
78% HAPU doc on 
POD3.  
 
4.5% reported within 
24hrs after OR. 
NOTE: Pts with PI 
documented in first 
24hrs deemed POA, 
but no description of 
pts admitted directly 
to OR, resulting in 
potentially missed 
PI. 
Shen et al 
2015 
Retrospective 
Study with 
propensity 
score 
matching  
III A  286 CT Surg 
Pts adults and 
peds 
(China) 
To investigate 
the 
relationship 
between 
length of 
16.4% (95% 
CI: 12.3-21.2) 
Peds 4.3%, 
Adults 18.8% 
Age, Disease 
Category, 
Corticosteroids 
(p<0.05).  
Time on CPB not 
sig. Sex, weight, 
introp vasoactive and 
post op vasoactive 
agents not sig.  
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 OR ICU 
surgery and 
incidence of 
PI in 
cardiovascular 
surgical 
patients.  
  Length of Surgery 
sig diff between 
group with/without 
PI (p=0.03).  
Borghardt, 
et al, 2015 
Prospective 
Cohort Study 
III B 77 patients 
from mixed 
ICU population 
(Brazil).  
 
ICU Mixed 
Identify the 
incidence of 
PI and 
describe the 
factors 
associated 
with its 
development 
in adults 
hospitalized 
in ICU. 
17 PI 
 
22% (95% 
CI: 12.6, 
31.5) 
 
Sig values in 
bivariate analysis 
LOS>10 days (P-
.000) 
CHF Yes: (P-.008) 
Death: (p-0.001) 
Braden Risk <11 
(p.003) 
 
5 CHF pts/4 
developed PI 
 
59% of PI positive 
pts died 
Kang & 
Zhai, 2015 
Meta-analysis 
of Surgical 
Patient PI risk 
and DM 
I A (? 
Level of 
sig less 
since no 
RCT in 
analysis?) 
13 Studies with 
2367 patients 
and 12053 
controls.  
 
Surgery types; 
Cardiac (4), 
General (5), 
Hip Fracture 
To assess 
diabetes as a 
risk factor for 
PI in patients 
undergoing 
different types 
of surgery.  
Pooled OR 
1.74 
(95%CI= 
1.40-2.15, 
I2=51.1%) 
 
Cardiac 
Studies: 
OR of PI in DM 
patients significant in 
all 4 Cardiac Surgery 
Studies  
What was the OR 
Restricted movement 
from cardiac assist 
devices (balloon 
pump, LVAD, and 
heart failure) 
considered to be 
contributing factors 
 
No increased PI 
incidence observed 
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(2), LE Amp 
(2) 
OR=2.0, 
95%CI=1.42-
2.82, I2= 0%;  
in pts undergoing 
Hip Surgery 
Cox & 
Roche 2015 
Retrospective 
correlational 
III A  306 Patients 
2 ICUs 
 
Medical-
Surgical and 
Cardiac 
Surgery ICU 
 
Examine 
associations 
between type, 
dose and 
duration of 
administration 
of vasopressor 
agents of PI in 
ICU patients 
in medical-
surgical and 
CT surgery 
units and 
examine 
factor 
significantly 
predictive of 
development 
of PI.  
13% (41/306)  39% of PI DTI; 56% 
sacrum 
 
84% (257/306) 
Received 
norepinephrine. 
 
37/41 (90% 
norepinephrine) 
 
Log regression 
predictors:  
1. Arrest (B=1.359, 
p=0.05 OR 3.894, 
CI=0.998-
15.118),  
2. Mechanical 
ventilation longer 
than 72 hours 
(B=3.161; 
P<.001; 
OR=23.604, 
Pts with PI had sig 
longer infusion times 
of vasopressin (32 vs 
87 hours; p=0.005) 
longer infusion times 
of high dose 
vasopressin (20 vs. 
57 hours, p=0.03).  
 
Pts receiving 2 
pressors significant 
in PI pts (norepi and 
vasopressin 
(X2=39.3, p<0.001) 
 
Longer infusion 
times at a dose at 
0.03 U/min or higher 
may be “tipping 
point” for PI 
development. 
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95%CI 6.427-
86.668 
3. Hours MAP less 
than 60mmhg 
while on pressor 
(B=0.092; 
P=0.01; 
OR=1.096; 
95%CI= 1.020-
1.178 
4. Admin 
Vasopressin 
(B=1.572, 
P=0.004; OR 
4.816; 95% CI 
1.666-13.925 
5. Cardiac diagnosis 
at ICU admission 
(B=-3.360, 
P=0.03; OR 
0.035; 
95%CI=0.002-
0.764.  
Rao et al, 
2016 
Systematic 
Review 
III A 12 Studies 
 
Mixed 
Population:  
Critical Care, 
Identify risk 
factors 
associated 
with PI 
development 
among 
Not reported PREOP RISKS 
SCI (OR 16.8) 
HX PI (OR 13.51) 
Noted absence of 
DTI discussion in the 
research for Cardiac 
Surgery Patients. 
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Surgical ICU or 
Cardiac 
Surgery 
Populations  
 
OR/ICU 
Studies 
critically ill, 
adult, cardiac 
surgery 
patients.  
Skin prob in Pu areas 
(OR 4.7) 
HD 24hrs (OR 4.77) 
HD 48 hrs. (OR 9.43) 
Creatinine >3 mg/dl 
(OR 3.70) 
Limited Mobility (OR 
2.27 and 4.42 based 
on 2 studies) 
Fecal INC (OR 3.27) 
Age (OR 1.03, 2.9, 
5.38 in 3 studies) 
Vascular Disease (OR 
2.95, 4.51, 1.80 in 3 
studies) 
Anemia (OR 2.81) 
Severity of Illness 
(OR 2.49, 3.40, 2.32 
in 3 studies). 
DM (OR 2.70, 1.85, 
1.49 in 4 studies) 
Malnut (OR 1.61) 
Malig Tumor (OR 
1.48) 
Suggest “hypoxic-
reperfusion” is 
linked to DTI and 
has not been 
adequately 
represented in the 
theoretical 
framework of PI 
development.  
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Pain (OR 1.43) 
Gen Skin problem 
(OR 1.34) 
Low Preop Braden 
(OR 1.22, 1.21 in 2 
studies) 
Low wt/BMI (OR 
1.01, 1.03 in 2 
studies) 
Admit Hgb (no OR 
listed) 
INTRAOP 
Friction/shear (OR 
5.72, 1.72 in 2 
studies) 
LOS > 3day (OR 
2.76) 
Total # surgeries (OR 
2.23) 
Total time in OR (OR 
1.07) 
Hours in ICU (OR 
1.01) 
POSTOP 
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Vasopressor (OR 
1.02, 6.05, 8.11, 1.33 
in 4 studies) 
Mech Vent (OR 4.82) 
Sedative drug (OR 
1.61) 
Post op Steroids and 
Post op Braden (No 
OR listed).  
 
 
Robich, et 
al 2017 
Retrospective  III A N=588,417; 
n=4377 Never 
Events  
 
OR/ICU 
Evaluated the 
nature, risk 
factors, and 
outcomes of 
never events 
following 
CABG, valve 
repair or 
replacement 
or thoracic 
aneurysm 
repair.  
4% PI Stage 
¾ over 8-year 
range (0% 
2003-2007) 
(12% 2008-
2011) 
Risk factors reported  
for all possible never 
events. Pressure 
ulcers not reported 
individually. 
 
Never events 
significant for higher 
Mortality, LOS, 
Hospital Cost. 
Sig risk factors of all 
never events 
matching previously 
reported PI risks: 
(weight loss, cancer, 
diabetes, CHF, 
Gender, Ethnicity, 
HTN, Age, ) 
Coagulopathy)These 
were significant in 
bivariate and the first 
column in 
multivariate 
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Lu, et al 
2017 
Prospective 
Consecutive 
Cohort  
III A 149 Patients  
(China)  
 
OR/ICU 
To build a 
new 
nomogram 
score and test 
its calibration 
and 
discrimination 
power for 
predicting 
surgical PI in 
cardiovascular 
surgical 
patients.  
24.8% (94% 
CI 18.1-32.6)  
Sig level of <.10 for 
Log Reg model: 
Valvular Disease 
(p=0.063) CAD 
p<0.03; Wt (p< 
0.091), Surgery 
duration p<0.036; 
Corticosteroids (p < ; 
OR for these factors? 
94.6% Stage 1 PI, 
Rest Stg 2. Not 
significant: gender, 
wt, alb level, smoke 
status, DM, CPB 
duration, post op 
mech vent duration, 
vasoactive agents 
intra or post op were 
not different between 
PI/No PI (p>.10).  
 
Authors developed 
predictive nomogram 
with significant 
goodness of fit where 
by pts with 
probability scores 
greater than 0.25 
should be considered 
high risk.  
Kirkland-
Kyhn, et al 
2017 
5-year 
Retrospective 
Descriptive 
III B 119 patients 
(US) 
 
7 ICUs (cardiac 
surgery, trauma 
surgery, burn 
surgery, med-
Identify 
common 
patient 
characteristics 
and factors 
that contribute 
to 
development 
47 HAPU, 72 
non-PU 
Dialysis OR 4.0 
(95%CI--.06-0.99, 
p=0.05) 
 
Shock state (yes/no) 
OR 10.0 (95%CI 
0.025-0.43, p=0.002) 
For every hour in 
surgery odds of DTI 
increased by 20% 
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surgery, 
neurosurgery, 
medical, 
transfer ICU 
of DTIs that 
evolved into 
stage 3, stage 
3 and 
unstageable 
HAPU in ICU 
patients. 
Secondary 
purpose to 
define 
specific 
parameters for 
risk factors to 
identify 
patients at risk 
for HAPU 
within ICU 
Population.  
 
DBP OR 0.93 
(95%CI 0.88-0.99, 
p=0.02) 
 
Time surgery in 
Hours OR 1.20 (95% 
1.07-1.33, p=0.001).  
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Key to abbreviations in the table: ALB-albumin; CAD-Coronary artery disease; CPB-
cardiopulmonary bypass; DBP-diastolic blood pressure; DM-diabetes mellitus; CT surg-
cardiothoracic surgery; HAPU-Hospital acquired pressure ulcer; Hgb- Hemoglobin; HCT-
hematocrit; HD-Hemodialysis; HTN-hypertension; ICU-Intensive Care Unit; INC-
incontinence; intraop-intraoperative; LOS-Length of stay; OR-operating room; POD-Post 
operative day; SBP-systolic blood pressure; SCI-spinal cord injury; wt.-Weight 
 
 
TABLE 3: Common Risk Factors of All Included Studies  
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Conceptual Framework 
 
 
Conceptual Framework of Pressure Injury Development in Cardiac Surgery Patients 
 
 
Figure 4. As described below, the theoretical development of pressure injuries in the cardiac 
surgery patient from baseline biobehavioral risk factors and influence of immobility and care 
factors on the cumulative and repetitive process of oxidant injury following a pressure and shear 
event. Ultimately, repetitive injury leads to pressure injury when there is imbalance between 
oxidant injury and reparative mechanisms. Oxidant injury may be exacerbated by baseline 
biobehavioral risk factors, which alter host inflammatory response, such as anxiety and 
depression. * Denotes protective mechanism. 
 
 
 
Description of Conceptual Framework 
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Given the complexities of PI etiology and the relative unknowns that remain, I seek an 
estimation of the truth, and therefore will utilize the philosophical perspective of post-positivism 
(Creswell, 2013). The four assumptions associated with this perspective are as follows: 1.) An 
ontological belief that there is only one reality separate from and incapable of being understood 
by all; 2) Epistemologic position that robust research principles and statistics may be utilized to 
approximate the truth about reality, yet absolute truth will never be truly known; 3.) The 
axiological understanding that as the researcher, personal biases cannot be introduced into the 
research and limited interaction with the subjects is important; and 4.) Methodological 
importance of scientific inquiry with a goal to create new knowledge. Post-positivism is 
appropriate as the complexity of PI etiology will require multiple theories, methods, and 
approaches to seek new understanding of their development.  
Post-positivist philosophical assumptions inform the theoretical framework for the study 
of patient factors, behavioral conditions, biochemical pathophysiological pathways, and the role 
of the care factors in PI development. Thus, the framework reflects the post-positivist 
assumption that knowledge can be created by studying both observable and unobservable 
phenomena.  This framework was also developed through adaptation of prior conceptual models 
and evidence in the literature describing the links between critical cofactors, subsequent host 
tissue tolerance and PI risk (Bhargava, Chanmugam, & Herman, 2014; Braden & Bergstrom, 
1987; Coleman et al., 2014; Defloor, 1999; Claudia Gorecki et al., 2010). However, unique to 
this framework is the inclusion of the cumulative impact of repetitive pressure and shear events 
on progressive, uncontrolled oxidant injury. This is particularly important because prior research 
was based on the conceptualization of PI development in relation to a single pressure/shear 
event.  Yet, surgical patients sustain repeated injury through routine care and transitions of care 
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including in the emergency department, following prolonged time on the operating table, in the 
ICU, and during diagnostic procedures. Repeated instances of immobility and pressure/shear 
events necessitate consideration of ongoing and progressive injury potential. Thus, for the VAD-
TAH patient, these events occur from the pre-surgical suite, through operating room procedures 
and during immediate post-operative care in the ICU. Additionally, patients present with variable 
biobehavioral factors that influence response to these pre-intra-post-operative immobility and 
pressure/shear events. 
The conceptual framework is an overarching framework of the development of PI in the 
cardiac surgery patient, considering the cyclical complexity of PI development, including 
baseline biobehavioral risk factors, the care setting, and the biochemical response of injured 
tissue.  
Preoperative Risk and Baseline Tissue Tolerance 
Baseline demographic and biobehavioral cofactors (sex, age, race, type 1 and type 2 
diabetes, smoking, anxiety and depression) influence the patient’s tissue tolerance, namely, their 
ability to respond to inflammatory and structural damage following pressure/shear events. There 
are conflicting results as to whether sex is a predictor of PI development, however; heart disease 
disproportionately effects women and is the leading cause of death, with risk factors similar to 
that of PI (Bergstrom, Braden, Kemp, Champagne, & Ruby, 1996; Lindgren et al., 2005; Xu, 
Murphy, Kochanek, & Bastian, 2016).  
Age is associated with a higher risk for PI development in multiple studies of cardiac 
surgery patients and is associated with risk during operative procedures (Chen, Shen, Xu, Zhang, 
& Wu, 2015; Cox, 2011, 2011; Feuchtinger et al., 2005; Halfens, Van Achterberg, & Bal, 2000; 
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Lindgren, Unosson, Fredrikson, & Ek, 2004; Lumbley, Ali, & Tchokouani, 2014; Manzano et 
al., 2010; O’Brien et al., 2014; Papantonio, Wallop, & Kolodner, 1994; Perneger et al., 2002; 
Sewchuk, Padula, & Osborne, 2006; Slowikowski & Funk, 2010; Webster et al., 2011). African 
American race was found to be a predictor of PI in acute care hospitals (Fogerty et al., 2008) and 
African Americans were at higher risk than Caucasians in all age groups in another study 
(Fogerty, Guy, Barbul, Nanney, & Abumrad, 2009). Regarding diabetes mellitus (DM), a meta-
analysis of 2453 patients found that DM was significantly associated with PI (p <.00001) and the 
only independent risk factor for PI (Liu, He, & Chen, 2012), while intraoperatively, surgical 
patients with DM were 49% more likely to develop PI (Tschannen, Bates, Talsma, & Guo, 
2012). Smoking may impact the inflammatory and oxidative response following tissue injury, 
impair perfusion to the site and overall tissue oxygenation. Smoking was identified as a risk 
factor for PI development and has been included in risk assessment instruments (Suriadi et al., 
2007; Suriadi, Sanada, Sugama, Thigpen, & Subuh, 2008).  
The influence of care factors reflects the role of the provider, engagement of the patient 
and the preventive equipment for mitigating PI risk, such as:  turning and repositioning, specialty 
beds/surfaces, and patient education and understanding of risk, (Bergstrom et al., 2013; McInnes 
et al., 2015; Stone et al., 2015). These factors are reliably controlled at the proposed setting of 
research using setting specific PI prevention protocols that are the standard of care for 
intraoperative and postoperative settings, are integrated into the electronic health record, and are 
individualized to the patients based on subscale-scores of the Braden Risk Assessment Scale 
score, which directs escalating preventive interventions.  
 Depression and anxiety are identified as cofactors in the framework because they are 
prevalent conditions in the VAD-TAH population (17% and 42% respectively) (Huffman, 
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Celano, & Januzzi, 2010) compared to non-device cardiac counterparts (Estep et al., 2015; 
Reynard, Butler, McKee, Starling, & Gorodeski, 2014; Shapiro, Levin, & Oz, 1996; Snipelisky 
et al., 2015). Additionally, depression and anxiety are suggested to be associated with increased 
PI risk (Braden, 1998; Krause & Broderick, 2004; Krueger, Noonan, Williams, Trenaman, & 
Rivers, 2013) related to increased production of inflammatory cytokines, catecholamines, and 
corticosteroids by activation of the Hypothalamus-Pituitary-Axis and Sympathetic Medullary 
Axis, which is thought to increase risk of post-operative complications in cardiac patients 
(Doering, Moser, Lemankiewicz, Luper, & Khan, 2005). Thus, levels of depression and anxiety 
biologically contribute to PI risk in cardiac surgery patients through the following mechanisms: 
1.) Exacerbating the response to cellular damage and inflammation resulting from ischemia; 2.) 
Exacerbating control of subsequent re-injury during reperfusion which causes oxidative stress, 
DNA damage and apoptosis in the skeletal muscle; 3.) Alteration of systemic and cellular 
temperature exacerbating both ischemia and inflammation (Bhargava et al., 2014); and 4.) Care 
factors such as adherence to rehabilitation plans (turning, walking, repositioning) thereby 
increasing immobility time (Shapiro et al., 1996). Subsequently, depression and anxiety are 
linked to tissue tolerance, oxidant tolerance and the pressure/shear event itself as depicted in the 
conceptual model.  
 Next, the framework describes the cumulative nature of PI etiology. Pressure and shear 
events trigger inflammation, leading to decreased oxygen delivery to the muscle tissue, anaerobic 
respiration and the development of oxidant injury during ischemia.  This ischemic injury is then 
exacerbated when blood supply is returned (reperfusion) after repositioning the patient, leading 
to a secondary injury, reperfusion injury. Reperfusion is described as a complex mixture of 
biochemical inflammatory cascades that exacerbate ischemic injury, with both systemic and local 
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inflammatory response (Duehrkop & Rieben, 2014). Skeletal muscle (where PI injury starts) is 
more susceptible to ischemia than skin, bone or nerves due to its higher metabolic demand for 
oxygen (Berlowitz & Brienza, 2007; Wilson et al., 2015). Most muscle cell death occurs during 
the reperfusion phase and may progress after resolution of ischemia due to the response of the 
innate immune system propagating reactive oxygen species (ROS) production and subsequent 
lipid peroxidation (Kirisci et al., 2013; Wilson et al., 2015). The severity of reperfusion is 
determined by the time of ischemia, which is the amount of time the tissues are deprived of 
oxygen (Gefen et al., 2008; Leopold & Gefen, 2012). The best estimation of IR is immobility 
time and the risk for PI can be operationalized in the cardiac surgery patient by evaluating total 
time immobilized from perioperative unit through intensive care unit arrival, anesthesia time, and 
cardiopulmonary bypass time. There is a cumulative impact of oxidant stressors, with injury 
recovery versus injury progression dependent on the patient’s capacity to generate antioxidant, 
anti-complement, and an appropriately regulated innate immune response. Thus, damage to the 
tissues may continue following a single reperfusion event and be compounded when additional 
pressure and shear events occur, leading to further oxidant induced injury. 
Therefore, oxidative stress may be conceptualized as the individual’s tissue tolerance to 
oxygen (Rao et al., 2016). The amount of oxidant injury can be measured by levels of circulating 
F2-Isoprostane and corresponding urinary metabolites of 2,3, dinor-15- F2-Isoprostane and 
5,6,dihydro-15- F2-Isoprostane, which are established markers of oxidative stress (Milne, Dai, & 
Roberts, 2015; Morrow, Awad, Kato, et al., 1992; Morrow et al., 1990; Morrow, Awad, Boss, 
Blair, & Roberts, 1992). These markers are by-products of the arachidonic acid pathway 
expressed following excessive ROS production during hypoperfusion and IR, leading to lipid 
peroxidation of polyunsaturated fatty acids in the phospholipid bilayer of cell membranes (Milne 
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et al., 2015; Repetto et al., 2012). In summary, a cumulative cycle of oxidative stress develops 
following decreased perfusion, oxygenation and subsequent reperfusion after each pressure and 
shear event. Ultimately, oxidant injury alters tissue tolerance and leads to cell death and PI 
formation.  
Summary of Philosophy and Conceptual Framework  
 
Given the complexity of PI pathophysiology, it is recognized that gaining an absolute 
understanding of every pathologic mechanism is not possible. Additionally, a post-positivist 
paradigm emphasizes the fact that while all measurement is fallible, unobservable phenomena 
have existence and inform observable effects. Therefore, multiple measures, theories or data 
sources may be required to examine a phenomena utilizing strict adherence to well-designed 
methodological approaches to decrease bias and improve the probabilistic approximation of the 
truth (Houghton, Hunter, & Meskell, 2012).  
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ABSTRACT 
BACKGROUND 
Cardiac surgery patients undergoing on-pump cardiac surgery have some of the highest reported 
incidence and prevalence of pressure injuries (PI). A growing subset of cardiac surgery include 
patients with end-stage heart failure who undergo ventricular assist device (VAD) or total 
artificial heart (TAH) surgery. The specific risk factors for PI development remain unexplored. 
PURPOSE 
The aim of this dissertation research is to investigate the incidence and risk factors associated 
with PI development in patients undergoing VAD-TAH surgery, which will inform an overall 
developing program of research in PI etiology, risk reduction, and prevention in this high-risk 
population.  A full understanding of PI etiology is the foundation for risk reduction and 
prevention.   
METHODS 
A retrospective study of all VAD-TAH surgeries between 2010-2018 was performed  in a 
designated heart center at a large academic health system. The study evaluated the incidence of 
pressure ulcers by case, patient and incidence density for each of the respective 1000 patient days 
during the study period. Univariate statistics are reported by four different VAD-TAH devices. 
Variables significant in bivariate analysis were entered in a stepwise logistic regression model.  
RESULTS 
The final sample for investigation included 292 independent VAD-TAH surgical cases 
conducted in 265 patients. In total, 32 patients developed 45 pressure ulcers. The incidence of PI 
per all surgical cases was 11% (32/292), with PI incidence per patient of 12% (32/265). 
Incidence density was found to be (10/1000) 1% for 2010-2012, (12/1000) 1.2% for 2013-2015, 
and (10/920) 1.1% for 2016-2018 respectively. Logistic regression revealed significant predictor 
variables for pressure injury in the VAD-TAH population: age, mechanical ventilation time and 
preoperative Braden Risk Assessment score. Despite long OR and long total immobility times, 
the mean time to PI was 23 days after admission and over 14 days after surgery, indicating a low 
rate of intraoperative and ICU associated PI.  
CONCLUSIONS 
The overall incidence of pressure injury was much lower than anticipated given historical 
incidence of PI in non-device cardiac surgery patients. A prospective study to further investigate 
significant risk factors and identify potential preventive mechanisms that decreased PI incidence 
in this population is warranted.  
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INTRODUCTION 
 Pressure injuries (PI) are defined as, “a localized damage to the skin and underlying soft 
tissue usually over a bony prominence or related to a medical or other device. The injury can 
present as intact skin or an open ulcer and may be painful. The injury occurs because of intense 
and/or prolonged pressure in combination with shear. The tolerance of soft tissue for pressure 
and shear may also be affected by microclimate, nutrition, perfusion, co-morbidities and 
condition of the soft tissue.” (Edsberg, Black, Golberg, McNichol, Moore & Sieggreen, 2016). 
Globally, PI prevalence in all settings and patient ages ranges from 27.3% to 72.5%. (Haesler, 
2014; Vangilder, Macfarlane, & Meyer, 2008). In a review of acute care settings, prevalence 
ranges from 0-49% contingent on the care setting and varies with patient population. It has been 
estimated that of patients who sustain a PI, over 2.5 million patients subsequently develop (PI) 
resulting in 60,000 deaths annually in the United States. (The Joint Commission, 2008). In the 
U.S., PI treatment costs may exceed $26.8 billion dollars annually (Padula & Delarmente, 2019). 
Over the past two decades, over 100 risk factors have been associated with the development of 
PI. However, these risk factors and associated prevention measures have not been adequately 
investigated across various cardiac surgery sub-populations (Ettema, et al., 2014). For example, 
intraoperative incidence rates in non-device cardiac surgery have been reported as high as 
29.5%, (Feuchtinger, Halfens, & Dassen, 2005; Rao, Preston, Strauss, Stamm, & Zalman, 2016). 
Subsequent prospective cohort studies of subpopulations such as cardiac surgery bypass grafting 
(CABG), the most commonly studied cardiac surgical intervention, have shown incidence rates 
as high as 53.4% in the cardiac ICU (Schuurman, Schoonhoven, Keller, & van Ramshorst, 2009) 
and 49% immediately after cardiac surgical procedures ( Feuchtinger et al., 2007). However, the 
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specific risk factors for the development of PI in ventricular assist device (VAD) and total 
artificial heart patients (TAH) remain unexplored (Brindle, 2019,[unpublished data]).  
Pressure Injury Etiology 
 The complexity of PI etiology involves the interplay of many pathophysiological 
processes; however, all of these processes arise from two primary pathophysiologic concepts: 
ischemia and direct deformation injury (Oomens, Bader, Loerakker, & Baaijens, 2015). First, 
ischemia results from prolonged compression of the skin and subcutaneous tissues leading to 
decreased perfusion, lymphatic impairment, tissue hypoxia and ischemia with subsequent 
reperfusion injury when blood flow is restored (ischemia-reperfusion or IR). This results in 
intravascular inflammation, complement activation, response of the innate immune system, 
oxidative stress through the build-up of metabolic waste products and mitochondrial 
dysregulation with ultimate activation of apoptosis and necrosis pathways (Gefen, Farid, & 
Shaywitz, 2013; Kirisci, Oktar, Ozogul, Oyar, Akyol, Dermirtas & Arslan, 2013; Puntel, 
Carvalho, Dobrachinski, Salgueiro & Puntel, 2013; Repetto, Semprine, & Boveris, 2012). 
Second, direct deformation injury results from the application of pressure and specifically shear 
forces to the tissues, where cell death is caused by significantly altering cell shape leading to 
cytoskeletal damage of the cell membrane. Direct deformation injury may cause cell death in the 
presence of adequate perfusion and oxygenation (Gefen, van Nierop, Bader, & Oomens, 2008; 
Oomens et al., 2015; Oomens, Loerakker, & Bader, 2010). Therefore, PI may form following 
prolonged hypoperfusion either related to ischemia and corresponding reperfusion injury or a 
short duration of intense deformation of the tissues leading to direct cellular injury.  These two 
processes, ischemia and direct deformation, are relevant to the cardiac surgery population 
because of prolonged periods of immobility experienced on the operating table, compromised 
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tissue tolerance and repetitive nature of pressure shear injury and altered systemic inflammatory 
response to injury 
  In CABG patients, Feuchtinger and colleagues reported that 47% of PI presented on post-
operative day 0, with the remaining 15% developing between day 1 and day 7 after surgery. 
Additionally, in a study of 135,701 CABG surgeries in the New York state database, patients 
with mental disorders (schizophrenia, major depression, dementia, bipolar disorder, and other 
psychiatric conditions) were found to have higher rates of PI than those without mental disorders 
(7.3/1000 vs. 1.8/1000; AOR 1.42, p=.006) (Li, Glance, Cai, & Mikael, 2008). Specifically, 
depression and anxiety are suggested to be associated with increased PI risk (Braden, 1998; 
Krause & Broderick, 2004; Krueger, Noonan, Williams, Trenaman, & Rivers, 2013) related to 
increased production of inflammatory cytokines, catecholamines, and corticosteroids by 
activation of the Hypothalamus-Pituitary-Axis and Sympathetic Medullary Axis, which is 
thought to increase risk of post-operative complications in cardiac patients (Doering, Moser, 
Lemankiewicz, Luper, & Khan, 2005)..  
A systematic review of the literature identified that the most common predictors for 
cardiac surgery patients after multivariate analysis included: American Society of Anesthesia 
(ASA) score, age, diabetes, hypotension, cardiac arrest, intravenous corticosteroids, basal 
metabolic index, surgery time, severity of cardiac disease, Braden Risk Assessment score and 
mechanical ventilation (Brindle, 2019, [unpublished data] ). However, risk factors have not been 
adequately investigated in patients with purportedly very high risk based on PI etiology and prior 
research, such as those with advanced heart failure most of whom require surgical intervention  
Pressure Injuries in Advanced Heart Failure Patients  
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A growing subset of the cardiac surgery patient population includes patients with 
advancing heart failure (HF) that require implantable ventricular assist devices or a total artificial 
heart (VAD-TAH).  While heart transplantation is a successful treatment for end stage HF 
patients, it is reported that this is available for less than 10% of patients due to severe shortage of 
donor organs (Aissaoui, Jouan, Gourjault, Diebold, Ortuno, Hamdan, et al., 2018). In the U.S., 
the number of persons with HF is anticipated to exceed eight million people by 2030 and is 
projected to be the leading cause of disability (Silva Enciso, 2016).  One retrospective study in 
patients hospitalized with systolic HF investigated length of stay (LOS), in-hospital mortality 
and associated predictors. Data was extrapolated from three payer based research databases 
(Allen, Smoyer Tomic, Wilson, Smith, & Agodoa, 2013). Of the 17,517 patients identified in the 
study, PI were present in 4% of subjects and increased LOS by 1.36 days (p<0.0001) in every 
payer category (commercial 158/4109; Medicaid 76/2118; Medicare 446/11,370), evidencing a 
significant patient and economic burden. Due to the high rate of PI in the cardiac surgery 
population, the impact of VAD-TAH surgery on PI development warrants investigation. While 
inferences can be made to guide research and patient care, patients undergoing VAD-TAH 
procedures may differ in risk profile from patients requiring a CABG procedure secondary to: 1) 
nature and length of the VAD-TAH procedure, 2) prolonged lengths of stay (LOS) associated 
with VAD-TAH procedures, and 3) abnormal or pulseless blood flow 4) physiological 
vulnerability and comorbidities of patients with advanced HF.  
Given the high prevalence of PI associated with CABG procedure and the additional 
vulnerability associated with advanced HF and VAD-TAH surgical procedures, it is 
hypothesized that the VAD-TAH patient is at the highest level of risk for PI development; 
however, the actual incidence is unknown, representing a large gap in our current understanding 
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of PI in this population.  With the increasing prevalence of advanced HF and resultant need for 
high risk VAD-TAH procedures, developing a PI further compounds significant complications 
that may result in additional physical, psychological and social impacts to patients and a high 
financial burden for the U.S. healthcare system.  Therefore, the aim of this dissertation research 
is to investigate the incidence and risk factors associated with PI development in patients 
undergoing VAD-TAH surgery, which will inform an overall developing program of research in 
PI etiology, risk reduction, and prevention in this high-risk population.  A full understanding of 
PI etiology is the foundation for risk reduction and prevention.    
Specific Aims: 
The primary aim of this study is to determine the incidence, natural history, and odds of 
PI development in the VAD-TAH population. The secondary aim is to explore a panel of 
cofactors as predictor variables in the development of pressure ulcers in the VAD-TAH 
population. Next, a sub-analysis of the research seeks to compare the association between three 
immobility times (total immobility time, operating room anesthesia time, cardiopulmonary 
bypass time) and risk of PI development. Finally, the third aim of this research seeks to explore 
the biobehavioral relationship between preoperative diagnosis of depression and anxiety, on PI 
development.  
Methods 
 The design for this study was informed by a systematic review of the literature using 
PRISMA methodology, which returned zero studies involving PI incidence or risk factors for PI 
in the VAD-TAH population (Brindle, 2019, unpublished data). Predictor variable selection for 
this study is further described in the systematic review. Following Institutional Review Board 
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approval, an eight-year retrospective cohort study utilizing the Virginia Commonwealth 
University Health System Pauley Heart Center VAD-TAH database for study years 2010-2018 
was performed. Study years 2010-2018 were selected due to known improvements made in the 
electronic health record (EHR) in 2010, enhancing PI reporting, and documentation. During this 
period, an informatics assessment of EHR accuracy for pressure ulcer documentation and staging 
reported an 89% positive predictive value (PPV) for pressure ulcer diagnosis and 94% PPV for 
pressure ulcer staging by clinical staff (unpublished data, VCU Health). Auto-consultation of PI 
expert certified wound-ostomy-continence nurses by the EHR to validate pressure ulcer 
diagnosis and staging further enhanced accuracy.  
The study group included all ventricular assist device (Heartware-HVAD, Heartware 
International Inc., Framingham, MA; Heartmate II (HM 2) & Heartmate III (HM3), Thoratec-
Abbott Laboratories, Abbott Park, IL) or total artificial heart surgeries (50-70cc TAH with 
companion or freedom driver, Syncardia, Tucson, AZ). Inclusion criteria included all patients 
undergoing VAD-TAH surgery, who were 18 years and older. Exclusion criteria included: 1) 
patients who did not receive cardiopulmonary bypass (off-pump procedures); 2) had VAD-TAH 
to orthotopic heart transplant surgery; 3) expired prior to postoperative day five; 4) pregnant 
women; 5) patients less than 18 years of age 6) department of corrections population and 7) 
patients who had pre-existing PI present on admission. Some subjects had multiple admissions 
for subsequent device surgeries during the study time-period, such as having a VAD replaced or 
transitioning from VAD to TAH. However, in all cases, these surgeries were months to years 
removed from the original surgery and therefore, all surgical events were admitted provided they 
met inclusion/exclusion criteria for each individual surgery. Due to the lack of available 
occurrence rates in the literature for PI in VAD-TAH patients, rule of thumb considerations were 
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used for effect size and sample size requirements by allowing for at least 10 PI events per 
variable (20 total) indicating a necessary sample size of at least 200 patients for retrospective 
review (Kellar & Kelvin, 2012, p. 327; Lance & Vandenberg, 2009). 
Measures 
 An existing research database created by the department of cardiac surgery at our 
university hospital was utilized for this research study. Research coordinators for the department 
were responsible for inputting data from the VCU Internal Quality Dataset into the VAD-TAH 
database. All (100%) of patients receiving VAD-TAH devices have been inputted into this 
database. The VAD-TAH database was provided via encrypted, password protected access to 
ensure confidentiality and accessed by the study PI after IRB approval on August 27th, 2018. The 
database was then deidentified using a heuristic method by the author (CTB) and patients were 
removed who were not in the study period of 2010-2018, or who were listed as having expired 
before post-operative day 5. The database was then augmented by adding the specific study 
variables to be investigated. All data was entered by the study principle investigator. Information 
bias was controlled using a data collection tool developed to guide the same process for data 
abstraction for each surgical case. Biological gender at birth (male or female) was recorded and 
ethnicity was defined as Caucasian, Black or African-American, Hispanic, or other. BMI was 
defined as underweight (<18.5), normal weight (18.6-24.9), overweight (25-29.9) and obese 
(>30). New York Heart Association Heart Failure Classification Scale was utilized to identify 
preoperative morbidity (1-4). Preoperative Braden Risk Assessment Scale scores were defined as 
low risk (23-18), medium risk (17-13) and high risk (<13) respectively. American Society of 
Anesthesiologist Score (ASA) were documented from anesthesiologist or certified registered 
nurse anesthetist pre-operative assessments. ASA scale scores range from I (mild systemic 
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disease) to V (moribund patient not expected to survive without surgical intervention) (Dripps, 
Lamont, & Eckenhoff, 1961). Anxiety and depression were defined by preoperative diagnosis of 
the respective conditions within history and physical or diagnostic code. Total number of 
surgeries was recorded and defined as the total number of surgeries (all types) during a single 
admission. Operative time was defined in minutes from the recorded on-table through off-table 
times recorded in the OR record. Bypass times were defined in minutes and recorded from the 
on-pump through off-pump time recorded in the OR record. Mean arterial pressure time less than 
60mmhg were recorded from OR anesthesia records and defined in minutes as displayed in 5-
minute recorded segments. Aortic cross clamp time was taken directly from the surgeons’ post-
operative note in minutes. Time to chest closure was defined by the time in minutes from the end 
of the initial implant surgery until sternal closure (with or without skin closure) at the surgery 
end time of a subsequent procedure. Length of stay was recorded in days from admission to 
discharge from the hospital. Mechanical ventilation time was recorded in minutes from the initial 
intubation either before or during the surgical procedure until extubation. For patients who were 
reintubated shortly after 1st extubation, the time in minutes until subsequent successful 
extubation was added to the initial time. Total immobility time was defined as the time in 
minutes from last turn before surgery, to time of first turn after return to ICU (all VAD-TAH 
patients went straight from OR to ICU without stopping in post anesthesia care unit). PI were 
defined as preoperative (documentation of PI from time of admission to assessment during 
perioperative pre-surgical assessment), intraoperative (defined as a PI documented from first skin 
assessment post-operatively to post-operative day 5), and post-operative (defined as 
documentation of PI from post-operative day 6 through time of last skin assessment before 
discharge). PI were first classified by staff nurses and then validated by certified wound ostomy 
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continence nurses using the updated 2016 National Pressure Ulcer Advisory Panel Pressure 
Ulcer Prevention and Treatment Guidelines (Edsberg, et al., 2016). 
Data Analysis 
PI incidence is reported by case-incidence and patient-incidence, defined as the number 
of new PI that developed divided by the total number of cases and total number of patients 
respectively. Incidence density is reported by associated years, defined by the number of new PI 
that develop during each1000 patient days over the study period. The primary null hypothesis for 
the study is that there are no differences between means comparing dichotomous PI groups (H1o: 
1=2) and the alternative hypothesis is that there are differences between group means (H1a: 
12). The secondary null hypothesis is that there are no differences between mean comparison 
of device types (H2o: HVAD=HM2=HM3=TAH) with an alternative stating there are 
differences (H2a: HVADHM2HM3TAH). Comparison of the presence of dichotomous 
preoperative diagnosis of anxiety or depression were compared to PI groups using Chi-square 
analysis respectively. An overall type I error of  = 0.05 and type II error of =0.2 was utilized. 
Missing data were left as missing and no imputation was performed. Descriptive statistics of the 
sample are reported by mean, standard deviation and 95% confidence intervals for normally 
distributed data and median and interquartile ranges for non-normally distributed data confirmed 
by QQ plots. Bivariate statistics comparing variables with the dichotomous dependent variable 
(pressure ulcer yes/no) were performed using Chi-Square for categorical variables and two-
sample t-tests for continuous variables. Multivariate logistic regression of predictors against the 
dichotomous outcome variable was performed in three steps by data clumping of significant 
bivariate demographic and clinical variables separately, then entering all significant predictors 
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into the final model. Per Hosmer and Leminshow’s model, all predictors were included with p 
values of 0.25 or less and entered into the final model , where stepwise backward removal of 
predictors with p> 0.05 was performed until only significant predictors with p<0.05 remained. 
Data are presented by mean, sample size, standard error, degrees of freedom, and odds ratio. 
Equality of error variance between the variables and dependent variable were checked for 
homoskedasticity. Cross product terms of related predictors were checked for multicollinearity. 
Separately, individual VAD-TAH device types were compared to continuous clinical variables 
using one-way analysis of variance (ANOVA) with post hoc Tukey HSD to investigate surgical 
procedure specific differences in group means.  
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RESULTS 
Figure 1. Case and Patient Inclusion Data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In total, 361 VAD-TAH cases were identified between study years 2010-2018. Following 
exclusions, the final sample for investigation included 292 independent VAD-TAH surgical 
cases conducted in 265 patients. In total, 32 patients developed 45 pressure ulcers. Despite some 
subjects having multiple surgical admissions during the study period, all pressure ulcers 
developed in individual patients during a single admission. The incidence of PI per all surgical 
cases was 11% (32/292), with PI incidence per patients of 12% (32/265). Incidence density was 
Total Database  
2010-2018 
N=361 VAD/TAH 
Surgeries 
After Initial Exclusion 
Criteria 
N=315 Surgeries 
Final Sample 
N=292 Surgical Cases 
In 265 Patients 
Exclusion After Full Chart 
Review: 
• Heart Transplant- 2 
• Expired- 9 
• PI On-Admit- 2 
• Off-Pump- 9 
• Still Admitted at time 
of study -1 
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found to be (10/1000) 1% for 2010-2012, (12/1000) 1.2% for 2013-2015, and (10/920) 1.1% for 
2016-2018 respectively. Mean hospital length of stay by device included 34.8 days for HVAD, 
43.5 for HM2, 35.5 for HM3 and 108.6 days for TAH. 
The distribution of all pressure ulcers by their period of development (preoperative, 
perioperative, post-operative >5 days) and mean time to ulceration are found in Table 1 and 2. 
Five pressure injuries developed in both the preoperative and intraoperative period respectively 
(1.7%), while 7.9% developed in the post-operative period. The mean time to ulceration for PI 
on all patients after admission was 28.3 days (n-32, =40,801.4 (mins) SD-36,140, 95% CI 
27306.1-54,296.7) with secondary ulcers occurring on 13 of 32 patients, ulcerating at 23.9 days 
after admission (n-13, =34459.4 (mins), SD-33,828.6, 95%CI 14017.0-54,901.8). Following the 
end of the VAD-TAH implant surgery, median days to PI development was 13.7 days (n-27, 
median 19,712 (mins), IQR 8538-30649) and 11.2 days (n-9, median 16,135 (mins), IQR 8567.0-
34244.5), reflecting the low rate of intraoperative development and high rate of post-operative 
ulceration respectively 
TABLE 1. DISTRIBUTION OF ALL PRESSURE ULCERS BY DEVELOPMENT 
PERIOD PER CASE (VAD/TAH) 
 Count Proportion 
No Pressure Ulcers 258 88.7% 
Pre-Operative  5 1.7% 
Intra-Operative  5 1.7% 
Post-Operative  23 7.9% 
Total  
 
 
291* 
100% 
 
*One patient had missing documentation of PI initiation and timing of presentation is unknown. 
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TABLE 2. Mean Time to Ulceration: Admission and End of Operative Case 
TIME UNTIL ULCERATION 
Variable n Mean 
(Minutes) 
SD 95% CI Time 
Conversion: 
Days Until 
ulceration 
Admit to 1st 
Document (PI 1) 
32 40801.4 36140.9 27306.1-54296.7 28.3  
Admit to 1st 
Document (PI 2) 
13 34459.4 33828.6 14017.0-54901.8 23.9 
 N Median 
(Minutes) 
IQR   
OR End Until 1st 
Document (PI 1) 
27 19712 8538-30649  13.7 
OR End Until 1st 
Document (PI 2) 
9 16135 8567.0-
34244.5 
 11.2 
Note: OR End to 1st Ulceration reflects only those 23 post-operative (1st occurring) pressure 
ulcers and secondary post-operative pressure ulcers occurring in patients with primary-
preoperative and intraoperative pressure ulcers.  
 
Comparison of Device Types 
 
The distribution of PI by VAD and TAH are found in Table 3. Five VAD patients 
developed pressure ulcers in the preoperative and intraoperative period respectively with 16 in 
the post-operative period for a total of 26 patients out of 234 (11.1%). Six TAH patients 
developed post-operative pressure ulcers (6/56) or 10.7%. Univariate distributive statistics for 
surgical variables by device type are shown in Table 4, with one-way ANOVA comparison of 
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means between surgical variables by device type in Table 5. Intraoperative variables included 
time parameters (indicative of potential ischemia/reperfusion potential) including total OR time, 
cardiopulmonary bypass time (CPB), mean arterial pressure time sustained at <60mmhg during 
the procedure, and aortic cross clamping time all in minutes. Total operating times were different 
between various devices. TAH OR times were significantly longer compared to HVAD (8.6 
hours vs. 7.2 hours p=0.0002) and HM3 (8.6 hours vs. 7.3 hours p=0.0245) respectfully and 
HM2 times were significantly longer than HVAD (8.2 hours vs. 7.2 hours p=0.0024). No other 
differences between devices and OR times were noted. Cardiopulmonary bypass times (CPB) 
also differed significantly between TAH and all VAD types (TAH 207 min vs. HVAD 118.8 
min, HM2 128.1 min, HM3 124 min, p=0.0001 respectively) however, there were no differences 
in CPB comparing the VAD devices (all p>0.7). Total time that mean arterial pressure (MAP) 
was below 60mmhg in minutes was compared by device type and showed significant variance 
between TAH and HVAD (21.6 vs. 7.2 minutes, p=0.0080), TAH and HM3 (21.6 vs. 1.7 
minutes p=0.0089), HM2 and HM3 (16.7 vs. 1.7 minutes, p=0.0466). Intraoperative aortic cross 
clamping time varied between groups with significantly longer periods noted between TAH and 
HVAD (154.4 vs. 8.9 minutes, p<0.0001), TAH and HM3 (154.4 vs 17.2 minutes, p<0.0001) 
and HVAD and HM2 (8.9 vs 11.7 minutes, p=0.0001).  
Post-operative surgical variables compared between device groups included total 
immobility time, mechanical ventilator time (minutes), time from surgery end to chest closure 
(minutes) and total length of stay in days by device. There were no significant differences noted 
in total immobility time or mechanical ventilator time between the respective devices. However, 
time to chest closure was significantly longer for TAH compared to HVAD (33.5 vs. 9.93 hours, 
p=0.0003) and HM3 (33.5 vs. 15.0 hours, p=0.0098) and TAH had significantly longer lengths 
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of stay compared to all VAD types (all p<0.0001). There were no differences between VAD 
types respectively in either group for these variables. 
Despite the disparity noted between the respective surgical variables above, the 
differences in PI occurrence between VAD-TAH groups was not significant (n=291, DF=2, 
2=0.027, =0.87) and there were no differences in PI development by operative period 
(pre/intra/post) between VAD-TAH patients (n-291, DF=3, 2=3.08, =0.38). Therefore, PI risk 
by predictors was evaluated by dichotomous groups of PI vs. no PI patients, irrespective of 
device.  
TABLE 3. DISTRIBUTION OF PRESSURE ULCERS BY IMPLANT TYPE 
  Operative Development Period 
Device Type Total Pressure 
Ulcers 
Pre Intra Post 
VAD 26/234 (11.1%) 5 5 16 
TAH 6/56 (10.7%)  0 0 6 
  
RUNNING HEAD: VAD PRESSURE INJURIES 
 
81 
 
TABLE 4. Distributive Statistics of Time Variables by Device Type 
VARIABLE  HVAD Heartmate II Heartmate III TAH 
Time-Minutes 
(hrs.) 
N Mean 
(Minutes) 
SD 95% CI N Mean 
(Minutes) 
SD 95% CI N Mean 
(Minutes) 
SD 95% 
CI 
N Mean 
(Minutes) 
SD 95% CI 
OR Time 
(hrs.) 
64 434.6 
(7.2) 
111.9 406.7-
462.6 
148 491.2 
(8.2) 
98.1 475.3-
507.2 
21 437.71 
(7.3) 
140.7 373.7-
501.8 
58 514.6 
(8.6) 
105.2 486.9-
542.2 
CPB Time 63 118.8 60.7 103.49-
134.07 
148 128.1 54.8 119.18-
137.0 
22 124.0 76.4 90.08-
157.83 
57 207 78.4 186.19-
227.81 
MAP Time in 
OR<60mmhg  
63 7.2 13.9 3.7-10.7 147 16.7 26.0 12.5-
20.9 
21 1.7 5.8 -0.9-
4.3 
58 21.6 33.0 13.0-
30.3 
Cross Clamp 
Time  
64 8.9 29.2 1.6-16.8 148 11.7 31.2 6.7-16.8 22 17.2 39.0 -0.1 -
34.5 
57 154.4 76.5 134.1-
174.7 
Total 
Immobility 
Time 
64 1313.8 
 
(21.9) 
1277.3 994.8-
1632.9 
148 1273.1 
 
(21.2) 
913.4 1124.7-
1421.5 
22 1063.5 
 
(17.7) 
832.2 694.6-
1432.5 
56 1419.7 
 
(23.7) 
664.0 1241.8-
1597.5 
Time OR End 
to Chest 
Closure 
64 595.8 
 
(9.93) 
1339.7 261.1-
930.4 
148 1265.1 
 
(21.1) 
2212.5 905.7-
1624.5 
22 901.8 
 
(15.0) 
192.3 100.4-
900.1 
58 2012.5 
 
(33.5) 
1920.2 1507.6-
2517.4 
Length of Stay 
(LOS) Days 
64 34.8 19.3 30.0-
39.6 
148 43.5 26.1 39.3-
47.8 
22 35.5 24.6 24.6-
46.4 
58 108.6 85.0 86.2-
130.9 
 N Mean 
(Minutes) 
SD 95% CI N Mean 
(Minute) 
SD 95% CI N Median 
(Minute) 
IQR  N Mean 
(Minutes) 
SD 95%CI 
Mechanical 
Vent Time 
64 6016.5 10573.4 3375.3-
8657.7 
148 6733.7 8366.7 5374.6-
8092.9 
21 1711 726-
5155.5 
 58 11893.1 27329.8 4707.1-
19079.1 
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(hrs.)  
(100.3) 
 
(112.2) 
 
(28.51) 
 
(198) 
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TABLE 5 (A-G). ANOVA Comparison of Means for Surgical Variables by Device Type 
A--OR Time by Device Type 
Device Device Difference SE 
Lower 
CL 
Upper 
CL 
p-
Value 
TAH HVAD 79.9 19.2 30.22 129.63 0.0002* 
TAH HM 3 76.8 27.0 7.02 146.65 0.0245* 
HM2 HVAD 56.6 15.9 15.60 97.62 0.0024* 
HM 2 HM 3 53.5 24.7 -10.40 117.45 0.1360 
TAH HM 2 23.3 16.4 -19.15 65.78 0.4887 
HM 3 HVAD 3.08 26.7 -65.85 72.03 0.9994 
B--CPB Time by Device 
Device Device Difference SE Lower CL Upper CL p-Value 
TAH HVAD 88.2 11.5 58.4 118.0 <.0001* 
TAH HM 3 83.0 15.8 42.1 124.0 <.0001* 
TAH HM 2 78.9 9.8 53.5 104.3 <.0001* 
HM 2 HVAD 9.3 9.5 -15.2 33.8 0.7603 
HM 3 HVAD 5.2 15.6 -35.2 45.5 0.9874 
HM 2 HM 3 4.1 14.4 -33.1 41.4 0.9918 
C--Mean Arterial Pressure Time in OR <60mmhg By Device Type 
Device Device Difference SE 
Lower 
CL 
Upper CL p-Value 
TAH HM 3 20.0 6.3 3.7 36.2 0.0089* 
HM 2 HM 3 15.0 5.8 0.2 29.9 0.0466* 
TAH HVAD 14.4 4.5 2.8 26.0 0.0080* 
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HM 2 HVAD 9.5 3.7 -0.1 19.1 0.0546 
HVAD HM 3 5.6 6.2 -10.5 21.6 0.8083 
TAH HM 2 4.9 3.8 -5.0 14.8 0.5700 
D--Cross Clamp Time by Device Type 
Device Device Difference SE Lower CL Upper CL p-Value 
TAH HVAD 145.5 8.0 124.8 166.2 <.0001* 
HVAD HM 2 142.7 6.9 124.9 160.4 <.0001* 
TAH HM 3 137.2 11.1 108.7 165.8 <.0001* 
HM 3 HVAD 8.3 10.9 -19.9 36.4 0.8722 
HM 3 HM 2 5.4 10.1 -20.6 31.4 0.9489 
HM 2 HVAD 2.8 6.6 -14.2 19.9 0.9734 
E--Total Immobility Time by Device Type 
Device Device Difference SE Lower CL Upper CL p-Value 
TAH HM 3 356.1 241.8 -268.8 981.1 0.4555 
HVAD HM 3 250.3 237.5 -363.6 864.1 0.7180 
HM 2 HM 3 209.6 219.6 -358.0 777.1 0.7755 
TAH HM 2 146.6 150.8 -243.1 536.3 0.7655 
TAH HVAD 105.9 175.9 -348.6 560.4 0.9314 
HVAD HM 2 40.7 143.8 -330.9 412.3 0.9921 
F--Mechanical Ventilator Time by Device Type 
Device Device Difference SE Lower CL Upper CL p-Value 
TAH HM 3 7864.2 3697.1 -1689.8 17418.2 0.1470 
TAH HVAD 5876.6 2631.8 -924.4 12677.6 0.1169 
TAH HM 2 5159.3 2248.9 -652.1 10970.8 0.1018 
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HM 2 HM 3 2704.9 3385.1 -6042.9 11452.7 0.8548 
HVAD HM 3 1987.6 3650.8 -7446.6 11421.9 0.9480 
HM 2 HVAD 717.2 2171.8 -4895.1 6329.6 0.9876 
G--Time OR End to Chest Closure by Device 
Device Device Difference SE Lower CL 
Upper 
CL 
p-
Value 
TAH HM 3 1512.3 480.3 271.0 2753.6 0.0098* 
TAH HVAD 1416.8 347.8 518.0 2315.5 0.0003* 
HM 2 HM 3 764.8 438.3 -367.9 1897.6 0.3025 
TAH HM 2 747.5 297.2 -20.5 1515.4 0.0597 
HM 2 HVAD 669.3 287.0 -72.4 1410.9 0.0932 
HVAD HM 3 95.6 474.1 -1129.6 1320.7 0.9971 
 
PRESSURE ULCER RISK FACTORS, STAGE & LOCATION  
 The stage and location of all 45 pressure ulcers that developed during the study period are 
reported in Table 6. The most common stage of pressure ulcer identified was deep tissue injury 
(DTI), representing 44% of all ulcers. The remainder included mucosal injuries (22%), stage 2 
(17.7%), unstageable (8.9%), and stage 3 (6.7%). There were no stage 1 or stage 4 pressure 
ulcers documented. The most common locations for occurrence included the buttocks (24.4%), 
the coccyx (15.6%), and the lip (11.1%). The sacrum, occiput and nares all developed 3 pressure 
ulcers in the 8-year study period (6.7%), whereas the heel, ischium and breast (all 2.2%) were the 
least reported. Of note, 13 of 45 ulcers were directly attributed to corresponding medical devices 
(28.8%) including nasogastric tubes, endotracheal tubes, and post-surgical bra.  
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TABLE 6. Distribution of Pressure Ulcers by Stage and Location 
 45 Pressure Ulcers Presented in 23 Total Patients 
  Group 2: Pressure Ulcer 
Stage Freq % Locations 
   Buttocks Coccyx Heel Ischium Sacrum Breast Occiput Nare Lip Ear 
1 0 0 0 0 0 0 0 0 0 0 0 0 
2 8 17.7% 3 2 0 0 0 1 0 0 0 1 
3 3 6.7% 0 1 0 1 1 0 0 0 0 0 
4 0 0 0 0 0 0 0 0 0 0 0 0 
DTI 20 44.4% 7 4 1 0 2 0 1 0 0 0 
Unstageable 4 8.9% 1 0 0 0 0 0 2 1 0 0 
Mucosal 10 22.2% 0 0 0 0 0 0 0 2 5 1 
Total 45 100% 11 7 1 1 3 1 3 3 5 2 
 % Location 24.4% 15.6% 2.2% 2.2% 6.7% 2.2% 6.7% 6.7% 11.1% 4.4% 
Device 
Related?  
13 28.8%           
 
Univariate statistics of the predictor variables and bivariate chi-square comparison of 
dependent variable groups are shown for categorical variables in Table 7 and continuous 
variables by t-test in Table 8. Comparison of demographic variables demonstrated no differences 
between gender, ethnicity, or smoking history in the 6 months prior to surgery for patients with 
and without PI. Additionally, baseline clinical diagnoses of diabetes, anxiety, depression, New 
York Heart Association (NYHA) heart failure classification, American Society of Anesthesia 
(ASA) score and use of intravenous corticosteroids preoperatively did not differ between patients 
with and without PI. However, significant differences were identified in three categorical 
variables including basal metabolic index (n-291, DF-3, 2=11.6, p=0.0088), preoperative 
Braden Risk assessment scores (n-290, DF-3, 2= 25.78, p<0.0001), and the occurrence of 
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myocardial infarction during admission (n-290, DF-1, 2=18.64, p<0.0001). In total, five 
continuous variables were found to be significantly different between PI groups, including: age 
(t- 3.52, DF 42.5, 95% CI 3.4-12.6, p-0.001), length of stay in days (t-2.45, DF 35.7, 95% CI 5.4-
57.1, p-0.019), total immobility time in minutes (t-2.8, DF 35.6, 95% CI 186.4, 1163.1, 
p=0.0081), mechanical ventilation time in minutes (t- 2.12, DF 32.5, 95% CI 855.5- 25413.3, 
p=0.037) and the total number of surgeries (t-2.33, DF 37.8, 95%CI 0.11- 1.61, p=0.025). 
Interestingly, there were no differences noted between patients with and without PI with respect 
to: total OR time, CPB time, time MAP <60mmhg, open chest time, aortic cross clamping time 
or the total days from admission prior to implantation of the device.  
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TABLE 7. Bivariate Comparison of Categorical Variables to Dependent Variable Groups  
Group 1: 
NO-PI 
 Group 2: 
YES- PI 
Comparison 
Chi-Square 
CATEGORICAL VARIABLES 
Variable Freq %  Freq %  
Gender 
Male 
Female 
 
193 
65 
 
74.8 
25.2 
  
25 
7 
 
78.1 
21.9 
n-291, DF 2, 2= 0.390 
p= 0.82 
Ethnicity      n-289, DF 4, 2=2.15, p=0.71 
Caucasian 120 46.6  18 56.2  
Black-A.A. 128 49.4  14 43.8  
Hispanic 6 2.3  0 0  
Other 4 1.6  0 0  
BMI      n-291, DF 3, 2=11.6, p=0.0088 
Under wt.<18.5 5 1.9  2 6.3  
Normal wt. (18.6-
24.9) 
39 15.1  11 34.4  
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Over wt: (25-
29.9) 
59 22.9  9 28.1  
Obese: >30 155 60.1  10 31.3  
DM 
No 
Yes 
 
149 
109 
 
57.8 
42.2 
  
17 
15 
 
53.1 
46.9 
n-290, DF 1, 2=0.25, p=0.62 
Anxiety 
No 
Yes 
 
236 
22 
 
91.5 
8.5 
  
30 
2 
 
93.8 
6.2 
n-290, DF-1, 2=0.194, p=0.66 
Depression 
No 
Yes 
 
238 
20 
 
92.2 
7.8 
  
28 
4 
 
87.5 
12.5 
n-290, DF-1, 2=0.845, p=0.36 
NYHA      n-289, DF 3, 2=5.27, p=0.15 
Class 1 3 11.7  2 6.3  
Class 2 3 11.7  1 3.1  
Class 3 115 44.9  12 37.5  
Class 4 135 52.7  17 53.1  
Pre-Op Braden      n-290, DF-3, 2= 25.78, p<0.0001 
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Low Risk (23-18) 191 73.9  12 37.5  
Med. Risk (17-13) 55 21.3  12 37.5  
High Risk (<13) 12 4.7  8 25.0  
IV 
Corticosteroids 
No 
Yes 
 
 
254 
4 
 
 
98.5 
1.5 
  
 
32 
0 
 
 
100 
0 
n-290, DF-1, 2=0.50, p=0.48 
Smoker <6 
Months 
No 
Yes 
 
 
230 
28 
 
 
89.1 
10.9 
  
 
25 
7 
 
 
78.1 
21.9 
n-290, DF-1, 2=3.259, p=0.07 
Type of Implant      n-290, DF-3, 2=1.82, p=0.61 
HVAD 58 22.5  5 15.6  
Heartmate 2 131 50.8  16 50.0  
Heartmate 3 18 6.9  4 12.5  
Total Artificial 
Heart 
51 19.8  7 21.9  
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Cardiac Arrest 
During Stay 
No 
Yes 
 
 
232 
25 
 
 
90.3 
9.7 
  
 
21 
12 
 
Blank page? 
63.6 
36.4 
n-290, DF-1, 2=18.64, p<0.0001 
ASA Score      n-290, DF-2, 2=5.09, p=0.08 
1 0 0  0 0  
2 0 0  0 0  
3 19 7.4  2 6.1  
4 229 89.1  27 81.8  
5 9 3.5  4 12.1  
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TABLE 8. Bivariate Comparison of Continuous Variables by Dependent Variable Groups  
CONTINOUS VARIABLES 
 Group 1: No Pressure Ulcer Group 2: Pressure Ulcer Group 
Comparison 
Variable n Mean SD 95% CI n Mean SD 95% CI T-Test 
Age 258 51.91 13.35 50.3-
53.6 
33 59.94 12.16 55.6-
64.3 
t- 3.52, DF 
42.5, 95% 
CI 3.4-12.6, 
p-0.001 
Days-
Admit to 
Implant 
258 9.17 8.88 8.09-
10.26 
33 10.09 6.25 7.87-
12.30 
t-0.75, DF 
50.2, 95% 
CI -1.53 – 
3.37, p=0.46 
LOS-Days 258 50.44 47.35 44.63-
56.24 
33 81.73 71.25 56.46-
106.99 
t-2.45, DF 
35.7, 95% 
CI 5.4-57.1, 
p-0.019 
OR Anesth 
Time 
(min) 
257 475.27 108.95 461.89-
488.66 
33 514.09 112.24 474.29-
553.88 
t-1.88, DF 
40.1, 95% -
3.0 -80.6, 
p=0.07 
CPB Time 
(min) 
256 138.97 69.83 130.38-
147.57 
33 160.97 76.31 133.91-
188.03 
t- 1.57, DF 
39.2, 95% 
CI -6.3, 
50.3, p=0.12 
Total 
Immobility 
(mins) 
256 1217.44 874.54 1109.8-
1325.1 
33 1892.18 1346.48 1414.74-
2369.62 
t-2.8, DF 
35.6, 95% 
CI 186.4, 
1163.1, 
p=0.0081 
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Cross 
Clamp 
(Mins) 
257 38.87 71.79 30.05-
47.69 
33 45.33 73.33 19.33-
71.33 
t-0.48, DF 
40.3, 95% 
CI -20.9, 
33.8, p=0.64 
OR-MAP 
<60 mmhg 
(mins) 
256 13.67 24.05 10.71-
16.63 
32 21.88 33.35 9.85-
33.90 
t-1.35, DF 
35.1, 95% 
CI -4.1, 
20.56, 
p=0.19 
OR-Chest 
Close 
(Mins) 
258 1141.8 1929.5 905.29-
1378.40 
33 1772.6 2257.1 972.24-
2572.92 
t- 1.54, DF 
38.2, 95% 
CI -200.9, 
1462.3, 
p=0.13 
Mech Vent 
Time 
(mins) 
 
257 
5935.38 8588.03 4880.42-
6990.33 
33 19069.79 34513.32 6831.9-
31307.68 
t- 2.12, DF 
32.5, 95% 
CI 855.5- 
25413.3, 
p=0.037 
Total # 
Surgeries 
258 2.14 1.67 1.93-
2.34 
33 3 2.03 2.28-
3.72 
t-2.33, DF 
37.8, 95%CI 
0.11- 1.61, 
p=0.025 
 
To determine the predictor variables for pressure injury development in the VAD-TAH 
population, the respective significant bivariate comparisons were entered into a multivariate, 
backward, stepwise regression model with results reported in Table 9. The final model suggests 
that age (df-1, 2=9.91, p=0.0016), pre-operative Braden Score (df-3, 2=15.88, p=0.0012) and 
mechanical ventilation time (df-1, 2=8.43, p=0.0037) are all significant predictors of PI in the 
VAD-TAH population. Odds ratio indicate for a unit change in age, the odds for pressure ulcer 
development are expected to increase by a factor of 1.06 (95% CI 1.02-1.09). For mechanical 
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ventilation time, for each unit change in minutes, the odds for pressure ulcer development are 
expected to increase by a factor of 1.00 (95% CI 1.000003-1.000067) holding all other variables 
constant. Preoperative Braden scores were dummy coded on three levels of risk: 0-Low Risk 
(23-18), 1-Medium Risk (17-13) and 2-High Risk (<13). Between risk groups, the odds of 
developing a PI are 3.73 times higher when a patient is medium risk compared to low risk (F1, 
df-3, 2=15.88, 95% CI 1.52-9.13, p=0.0040) and 9.21 times higher risk of developing a PI when 
a patient is considered high risk compared to low risk (F1, df-3, 
2=15.88, 95% CI, 2.79-30.39, 
p=0.0003).  
Table 9. Multivariate Logistic Regression of Significant Predictors and Odds Ratios 
Variable Nparm DF ChiSquare p-value 
Odds Ratio Lower 
95% 
Upper 
95% 
Age 1 1 9.91 0.0016 1.06 1.02 1.09 
Mech Vent T 1 1 8.43 0.0037 1.00 1.00 1.00 
Braden 0(23-18) 1-
(17-13) 2-(<13) 
3 3 15.88 0.0012 
   
Braden 1:0 
Braden 2:0 
Braden 0:1 
Braden 0:2 
   
0.0040 
0.0003 
0.0040 
0.0003 
3.73 
9.21 
0.27 
0.11 
1.52 
2.79 
0.11 
0.033 
9.13 
30.39 
0.66 
0.36 
 
DISCUSSION 
 
This study represents the first investigation of the development of PI in patients 
undergoing ventricular assist device or total artificial heart surgeries. In this retrospective 
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analysis, age, mechanical ventilation time and preoperative Braden Risk Assessment Score were 
the only significant predictors of PI development across all devices. Age is associated with a higher 
risk for PI development in multiple studies of cardiac surgery patients and is associated with risk during 
operative procedures, possibly related to physiologic and anatomical changes associated with increasing 
age such as muscle atrophy, rete-peg-papillary-dermis flattening and increasing tissue hypoxia (Chen, 
Shen, Xu, Zhang, & Wu, 2015; Cox, 2011, 2011; Feuchtinger et al., 2005; Halfens, Van Achterberg, & 
Bal, 2000; Lindgren, Unosson, Fredrikson, & Ek, 2004; Lumbley, Ali, & Tchokouani, 2014; Manzano et 
al., 2010; O’Brien et al., 2014; Papantonio, Wallop, & Kolodner, 1994; Perneger et al., 2002; Sewchuk, 
Padula, & Osborne, 2006; Slowikowski & Funk, 2010; Webster et al., 2011). Age related changes may 
impair tissue tolerance secondary to decreased tissue integrity during tissue loading and exacerbate the 
inflammatory response to injury. In bivariate analysis, this study shows that patients who developed PI 
were older than those patients without PI development (t-3.52, DF 42.5, 95% CI 3.4-12.6, p-0.001). 
Additionally, the study suggests that patients who developed PI spent significantly longer time on 
mechanical ventilation than those without PI (mean 13.24 days vs. 4.12 days; 2.12, DF 32.5, 95% CI 
855.5- 25413.3, p=0.037). Mechanical ventilation represents a risk for PI development secondary to 
prolonged head of bed elevation greater than 30 degrees, decreased mobility, and represents potential host 
complications in systemic tissue oxygenation. When considering age and mechanical ventilation in 
multivariate analysis, however, the low odds ratios (age OR= 1.06; mech vent OR=1.00) suggest a 50-50 
chance of developing PI for each predictor. However, when considering Braden Risk Assessment Score, 
the most significant predictor of PI was a Braden score indicative of high risk or <13, indicating  9 times 
greater odds for PI between high risk versus low risk patients preoperatively (p-0.0003, OR 9.21, 95% CI 
2.79-30.31). While patients with normal Braden Scores preoperatively are still in jeopardy of PI due to 
factors associated with the aforementioned operative and post-operative risks, patients with existing 
challenges in mobility, friction/shear, moisture, activity level, nutrition and sensory perception will be 
exacerbated by prolonged operating room and post-operative recovery periods demonstrated in the 
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various device types. Interestingly, however, the overall incidence density (1-1.2%) and patient 
incidence of 12.1% for this study is remarkably low given the historical rates of pressure ulcers 
reported in other non-device cardiac surgery studies.  
The VAD-TAH procedure is more invasive and has greater operating room times than 
CABG (3-6 hours) (Cotts, McGee, Myers, Naftel, Young, Kirklin & Grady , 2014) compared to 
7.2-8.6 hours shown in this study. Additionally, average LOS for CABG surgery is five days 
(Cotts et al., 2014; (El Banayosy, Kizner, Arusoglu, Morshuis, Brehm, 2014), while VAD and 
TAH average LOS ranged between 19.3 and 108.6 days in this study.  Next, VAD-TAH patients 
are further at risk due to more advanced heart failure with severely reduced cardiac function, 
whereas CABG patients have coronary artery occlusion with or without existing heart failure. 
This differentiation is significant because patients with advanced left ventricular failure or 
biventricular failure requiring VAD-TAH have significantly higher preoperative Anesthesia 
Severity Assessment (ASA) scale scores compared to CABG patients based upon their advanced 
HF. ASA scores greater than or equal to three are associated with higher operating room pressure 
ulcer rates (O’Brien, Shanks, Talsma, Brenner, & Ramachandran, 2014).  For each one point 
increase in ASA, the odds of developing PI have been reported to increase by 149% (Fred, Ford, 
Wagner, & Vanbrackle, 2012). This is significant because the VAD-TAH patients in this study 
were: ASA-3 (7.4%), ASA-4 (89.1%), ASA-5 (3.5%) indicating severe heart failure and high 
surgical risk.  
Additionally, this study presents the first attempt to capture total immobility time to 
account for cumulative preoperative, intraoperative and post-operative immobility to gauge the 
total supine ischemic, compression and deformation strain potential, exerted on the soft tissue of 
these patients. As time under compression and tissue strain reflect the potential extent of direct 
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tissue damage and potential severity of reperfusion injury, identification of surgical risk should 
not be confined to the time on the operating table alone. While CABG patients tend to have 
same-day progressive mobility practices which limit immobility after surgery, the VAD-TAH 
patients in this study averaged a staggering 21.2-23.7 hour of complete supine immobility and 
averaged 2.14-3 operations per patient, per admission. Yet again, the overall incidence of PI, 
especially in dependent bony prominences of the supine patient were less than expected. Reasons 
for extended immobility in this study were attributed to active bleeding, hemodynamic 
instability, and cardiac arrest. The difference between PI groups was significant for total 
immobility time in bivariate modeling (t-2.8, DF 35.6, 95% CI 186.4, 1163.1, p=0.0081) though 
not significant in the final multivariate model. Of interest, as hemodynamic instability is often a 
subjective determinant of patient positioning, it should be noted that the cardiac surgery ICU 
protocols for aggressive turning and positioning utilized during the study duration  have been 
previously published (Brindle, Malhotra, O'Rourke, Currie, Chadwick, Falls, et al., 2013). While  
adherence to these protocols was not measured in this study, a previous description of the 
effectiveness of these prevention practices specific to this cardiothoracic ICU was published 
(Cooper, Jones, & Currie, 2015). The authors described trends toward decreased PI rates despite 
increasing patient acuity and increasing numbers of extracorporeal membrane oxygenation use 
(ECMO) displaying a heightened culture of prevention and implementation of successful 
protocols in practice.  
In this study, not only was there a low rate of PI incidence, but most of the ulcerations 
developed after the intensive care unit (ICU) stay. Theoretically, most patients in this study 
remained pressure injury free through surgery, prolonged immobility, and vasopressors to 
control labile hemodynamic periods in the ICU, until a point at which they ulcerated, where 
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traditionally the patient would have been considered to be at lower risk compared to the 
perioperative through intensive care period. The large majority of PI development in the buttocks 
may reflect the high BMI habitus (60.1% BMI >30 vs. 31.3% BMI >30 in PI vs. no-PI groups; n-
291, DF 3, 2=11.6, p=0.0088) of the patients  in this study which naturally increases the loading 
and deformation of the buttocks tissues in comparison to the sacrum or ischium. In addition, 
Sprigle and Sonenblum recently described the relative differences in tissue thickness, 
deformation and frictional forces dependent upon the level of head of bed elevation compared to 
PI morphology (Sprigle & Sonenblum, 2019). In this study, mechanical ventilation time was a 
significant predictor of PI and during this period, the standard of practice is to maintain head of 
bed elevation at 30 degrees. However, it was not possible to measure exact head of bed angle or 
periods of different positions in the supine state which should be considered in future studies as it 
may impact tissue tolerance.  
Tissue tolerance, a concept specific to PI development, is multifactorial and refers to the 
susceptibility of developing a PI (Bhargava et al., 2014; Braden & Bergstrom, 1987; Coleman et 
al., 2014; Defloor, 1999). Tolerance of the individual tissues is defined by: 1) mechanical 
properties of tissue, 2) geometry (morphology) of the tissues and bones, 3) physiology and 
repair, and 4) transport of thermal properties (Coleman et al., 2013, 2014; Haesler, 2014). 
Therefore, a patient has a baseline capacity to respond to the negative impact of the forces 
leading to tissue injury, otherwise referred to as tissue tolerance. During hospitalization for 
cardiac surgery, the patient suffers repetitive tissue injuries from pressure and shear, each one 
exacerbating inflammation and structural damage within the tissue. This results in both an 
imbalance between available oxygen, metabolic demand for oxygen, and the build-up of oxygen 
free radicals (oxidative stress). Ultimately, if the frequency, duration, intensity, and repetitive 
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nature of pressure and shear injuries overwhelms the hosts ability to respond using reparative 
mechanisms, a PI may develop. The capacity of the patient to respond to inflammatory tissue 
damage and oxidative injury following pressure and shear events determines the progression of 
tissue injury and potential for and severity of cutaneous manifestation. Rao and colleagues 
referred to this specifically as a tissue tolerance for oxygen (2016). The patient then enters 
repeating cycles of pressure and shear events as they suffer further from periods of immobility in 
the ICU, elevated head of bed positions, immobility during diagnostic tests, and multiple surgical 
procedures, among others, depending on the patient’s condition. These subsequent events 
increase the damage caused by pressure and shear induced IR injury as the patient’s post-injury 
tissue tolerance is less capable of mitigating repeated oxidative insults to the damaged tissue. A 
patient undergoing cardiac surgery typically has multiple comorbidities such as advanced heart 
disease, impaired cardiac output or systemic perfusion/oxygenation, decreased mobility, 
polypharmacy, et al., which impacts the body’s ability to respond to insults and reduces overall 
tissue tolerance.  
Potential Preventive Mechanisms 
Two potential explanations for PI mitigation in this study include possible intrinsic and 
extrinsic factors. First, it is unknown what the impact of post-operative tissue perfusion changes 
are in the VAD-TAH patient. With immediate and considerable improvement in post-operative 
cardiac output following device implantation compared to that of the preoperative diseased heart, 
it is possible that tissue perfusion improved over their baseline HF state which provided 
improved circulation to at risk tissues. However, measuring blood pressure may be problematic 
especially in VAD patients due to reduced or absent pulse pressure with non-pulsatile flow. With 
these devices, pump speed is controlled by the clinician and increases in speed correspond to 
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increased left ventricular unloading, cardiac output and end-organ perfusion (Aissaoui et al., 
2018). In future prospective studies, it would be valuable to measure perfusion of the dependent 
tissues at risk for PI using ultrasound, hyperspectral and thermographic imaging or potentially 
with more invasive techniques. 
Next, the patients in this study benefitted from a robust, PI prevention program that 
spanned the continuum of care from admission, through the surgical procedure and during their 
extended stay. All patients admitted to the ICU both before and after surgery were placed on 
alternating low air loss (LAL) mattress on admission as standard of care. In addition, staff 
followed an extensive ICU prevention protocol that included heel offloading devices, 
prophylactic 5-layer foam dressings, turning and positioning systems, moisture wicking 
incontinence pads, skin moisturizers and barriers and fluidized positioners. In addition, nursing 
and respiratory therapy staff participated in joint medical device related PI prevention protocols 
with built in EHR guidance for preventive interventions based on Braden Scale sub-score risk. 
The high rate of device related pressure injuries found in this study may reflect the total number 
of devices these patients come out of surgery with, unknown adherence and consistency in 
implementing the prevention protocol and the challenge to prevent these injuries. While there 
was a device prevention protocol in place, a number of factors may lead to device PI 
development despite a prevention protocol such as: 1) high number of devices per patient, 2) 
competing demands and ability to access/view skin under devices, 3) device manufacturing and 
construction using rigid materials, 4)lack of sufficient evidence to guide prevention with all types 
of devices 5)role confusion between interprofessional staff as to who is managing devices, 6) 
inability to remove or offload devices due to life threatening or anatomically specific, individual 
patient needs. In the operating room, all supine patients in cardiac surgery OR were on 4-inch 
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viscoelastic foam mattresses that accommodated bariatric and normal BMI patients alike. In 
addition, patients had 5-layer prophylactic sacral foam dressings, fluidized positioners for 
protection of the occiput and either utilized heel offloading devices or 5-layer foam prophylactic 
heel dressings. After surgery, the patients were immediately transferred back onto their 
alternating pressure LAL mattresses. When transferred to step-down or on the general device 
floor, all beds continued to be either group-two static air mattresses or combination multilayer 
foam and air mattresses as the standard of care. The step-down and general floors similarly had 
prevention protocols which guided individualized prevention once the patient was out of the 
ICU. Due to the culture of prevention established across the organization, it is possible that the 
low rates of PI could be attributed to a high organizational awareness of risk and consistency in 
implementing preventive interventions. Therefore, the results shown in this study may not be 
generalized across other VAD-TAH operating organizations and should be compared to 
prospective studies in different facilities.  
Biobehavioral Factors 
One study aim was to determine whether there was a difference between preoperative 
diagnosis of anxiety and depression on PI development between groups. In this study, 
preoperative diagnosis of depression and anxiety were not found to be significant risk factors in 
either group (depression n-290, DF-1, 2=0.845, p=0.36; anxiety n-290, DF-1, 2=0.194, 
p=0.66). Depression and anxiety were investigated as cofactors in this study because they are 
prevalent conditions in the VAD-TAH population (17% and 42% respectively) (Huffman, 
Celano, & Januzzi, 2010) compared to non-device cardiac counterparts (Estep, Starling, 
Horstmanshof, Milano, Selzman, et al., 2015; Reynard, Butler, McKee, Starling, & Gorodeski, 
2014; Shapiro, Levin, & Oz, 1996; Snipelisky, Stulak, Schettle, Sharma, Kushwaha & Dunlay, 
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2015). Additionally, depression and anxiety are suggested to be associated with increased PI risk 
(Braden, 1998; Krause & Broderick, 2004; Krueger, Noonan, Williams, Trenaman, & Rivers, 
2013). Thus, levels of depression and anxiety and the associated level of allostatic load, may 
biologically contribute to PI risk in cardiac surgery patients through the following mechanisms: 
1. exacerbating the response to cellular damage and inflammation resulting from ischemia 
2. exacerbating control of subsequent re-injury during reperfusion which causes oxidative 
stress, DNA damage and apoptosis in the skeletal muscle  
3. alteration of systemic and cellular temperature exacerbating both ischemia and 
inflammation (Bhargava, Chanmugam, & Herman, 2014) 
4. care factors such as adherence to rehabilitation plans (turning, walking, repositioning) 
thereby increasing immobility time (Shapiro et al., 1996).  
However, the limitations of this study were the unknown practice of anesthesia and surgical 
providers on routine preoperative screening for depression and anxiety. As only a diagnostic 
code could be found in the patient’s problem list, the accuracy of identifying depression and 
anxiety in a retrospective design is questionable. In future studies, prospective collection of the 
generalized anxiety disorder 7-item (GAD-7 ) scale and the patient health questionnaire-9 
(PHQ-9) should be considered, as they are sensitive tools for the preoperative setting, are valid 
and reliable in the cardiac population and may predict cardiac mortality (Abed, Kloub, & 
Moser, 2014; Reynard et al., 2014). By utilizing these preoperative screening tools, the 
presence and severity of anxiety and depression could be modeled to gauge PI association. In 
addition, consideration for active pharmaceutical interventions before and after surgery may 
similarly be used as an indicator of the severity of these conditions in the future.  
LIMITATIONS 
RUNNING HEAD: VAD PRESSURE INJURIES 
 
103 
 
The limitations of this study include the retrospective design and availability of data 
within the medical record. Additionally, as there were no previous studies to guide selection of 
cofactors for PI in the VAD-TAH population, a surrogate population of non-device cardiac 
surgery patients guided variable selection (Brindle, 2019 in press). The inherent selection bias 
associated with surrogate population study selection, likely led to a lack of inclusion for other 
important cofactors. For example, Cox and Roche (2015) identified an incidence of 13% 
(41/306) in a retrospective correlational study of 306 patients in a medical surgical and cardiac 
surgical ICU. Of these pressure ulcers, 39% were DTPI and 56% were found on the sacrum. The 
authors identified significant risk factors specifically related to vasoactive medications with 
pressure ulcer patients having significantly longer infusion times of vasopressin (32 hours vs 87 
hours, p=0.005) and longer infusion times of high dose vasopressin (20 hours vs. 57 hours, 
p=0.03)  as significant in PI development (X2=39.3, p<0.001). The authors specifically 
commented that the dose of 0.03 U/min may be a tipping point for pressure injury development. 
In this study, vasopressor utilization and dose were not captured and may have a significant role 
in risk for PI in VAD-TAH patients given the multiple medications and considerable dose 
experienced by these patients. Future prospective studies should capture drug type, dose, and 
duration during the preoperative through post-operative period.  
Additionally, diabetes mellitus has been described as a significant predictor of operative 
PI in multiple studies but did not find significance in this study.  Liu and associates (2012) 
performed a meta-analysis of six studies (4 cardiac surgery, 2 mixed surgical populations) of 
2453 patients who had surgery, to investigate the effect of diabetes mellitus (DM) on the 
development of PI during surgical procedures. The incidence rate across studies was 11.8%, with 
no significant heterogeneity (X25 =1.98, p=0.85, I
2=0%) between the studies. All studies were 
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listed as IIB evidence and scoring a 7/8 for quality according to the Newcastle-Ottawa scale. The 
meta-analysis revealed that diabetes mellitus was significantly associated with the development 
of PI (OR 2.15 (95%CI: 1.62-2.84; Z-5.32, p<0.00001, fixed effects model OR=2.13). Even after 
the removal of one retrospective study, the odds were still found to be significant (OR=2.03) 
(Liu, He, & Chen, 2012). These findings were supported by a second meta-analysis of 13 studies 
including total comparison groups of patients with pressure ulcer (n=2367) and patients without 
(n=12053) showing DM to be a significant risk factor across surgical types  with a pooled odds 
ratio of 1.74 (95%CI= 1.40-2.15, I2=51.1%) (Kang & Zhai, 2015). When isolating the four 
studies involving cardiac surgery patients alone, DM remained a significant risk factor (OR=2.0, 
95%CI=1.42-2.82, I2= 0%). In this study, only a dichotomous inclusion of diabetes yes/no was 
included in the database as level of diabetes control evaluated by HgA1c was not recorded on all 
patients. In future prospective studies, evaluation of HgA1c may provide more depth of 
association by allowing for comparison of the dependent variable with the severity of the disease 
state. Finally, due to retrospective design there was no ability to utilize recently published 
operative risk assessment tools for intraoperative PI such as the Munro Scale or the American 
Operating Room Nurses Association Preoperative Risk Assessment Toolkit (Munro CA, 2010; 
“Prevention of Perioperative Pressure Injury Tool Kit - AORN,” n.d.) 
The low incidence of PI events in this study limit the ability to identify potentially 
significant variables. The research was conducted at a single, academic university quaternary 
medical center which limits generalizability. Finally, as PI prevention protocol adherence was 
not measured in this study, it is difficult to gauge whether the outcomes were associated with 
patient care factors or underlying physiologic protection.  
CONCLUSION 
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The overall incidence of pressure injury in this study was much lower than anticipated 
given historical incidence of PI in non-device cardiac surgery patients. This is an interesting 
finding given the increased severity of disease state and overall potential risk for PI evidenced by 
variables such as longer operating room times, immobility times, length of stay, etc., which were 
discovered. In this study, the primary null hypothesis is rejected in favor of the alternative 
hypothesis as age, mechanical ventilation time and preoperative Braden Risk Assessment score 
were determined to be significant predictors of pressure injury in the VAD-TAH population. The 
secondary null hypothesis is accepted as there were no differences found in the development of 
PI between TAH and VAD device types. Finally, the third null hypothesis was accepted as the 
study did not identify any association between preoperative diagnosis of depression or anxiety on 
pressure injury development. However, the limitation of retrospective review and potential 
contribution of depression and anxiety on pressure injury risk would be better investigated with 
prospective studies that gauge the severity of the conditions as potential predictors to PI. A 
prospective study to further investigate significant risk factors, end organ perfusion and identify 
potential preventive mechanisms that decreased PI incidence in this population is warranted.  
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Concluding Narrative 
The dissertation research described herein discussed the investigation of PI incidence, 
risk factors and predictor variables for the development of pressure injuries in cardiac surgery 
patients undergoing VAD-TAH surgeries. A systematic review using PRISMA methodology was 
unable to identify any articles which described the reported incidence, prevalence or risk factors 
for the VAD-TAH surgical population. Because of this, a review of a surrogate population 
including the on-pump CABG patient served to identify potential variables of further study. The 
systematic review suggested: ASA score, age, diabetes mellitus, cardiac arrest, preoperative 
corticosteroids, BMI, OR time, cardiac disease severity, and mechanical ventilation as potential 
risk factors to consider. The results guided the first, 8-year retrospective analysis of VAD and 
TAH patients to identify incidence, and predictors of PI development in a large academic 
university health center in the United States.  
 The retrospective study identified 361 VAD-TAH cases between study years 
2010-2018, with the final sample for investigation including 292 independent VAD-TAH 
surgical cases conducted in 265 patients. In total, 32 patients developed 45 pressure ulcers. 
Despite some subjects having multiple surgical admissions during the study period, all pressure 
ulcers developed in individual patients during a single admission. The incidence of PI per all 
surgical cases was 11% (32/292), with PI incidence per patient of 12% (32/265). Incidence 
density was found to be (10/1000) 1% for 2010-2012, (12/1000) 1.2% for 2013-2015, and 
(10/920) 1.1% for 2016-2018 respectively. Mean hospital length of stay by device included 34.8 
days for HVAD, 43.5 for HM2, 35.5 for HM3 and 108.6 days for TAH. The overall incidence of 
pressure injury in this study was much lower than anticipated given historical incidence of PI in 
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non-device cardiac surgery patients. This is an interesting finding given the increased severity of 
disease state and overall potential risk for PI evidenced by variables such as longer operating 
room times, immobility times, length of stay, etc., which were discovered. In this study, the 
primary null hypothesis is rejected in favor of the alternative hypothesis as age, mechanical 
ventilation time and preoperative Braden Risk Assessment score were determined to be 
significant predictors of pressure injury in the VAD-TAH population. The secondary null 
hypothesis is accepted as there were no differences found in the development of PI between 
TAH and VAD device types. Finally, the third null hypothesis was accepted as the study did not 
identify any association between preoperative diagnosis of depression or anxiety on pressure 
injury development. However, the limitation of retrospective review and potential contribution of 
depression and anxiety on pressure injury risk would be better investigated with prospective 
studies that gauge the severity of the conditions as potential predictors to PI.  
Given the outcomes of the systematic review which was not able to identify any existing 
research in VAD-TAH patients to guide a retrospective review, and the limitations of a 
retrospective review which increase the risk of accuracy via information bias and selection bias, 
the results of this dissertation study will inform future research.  
Because the incidence of PI in VAD-TAH patients was lower than expected, future 
studies should focus on both a prospective investigation to more accurately define predictor 
variable. For example, the secondary aim will be to evaluate the effect of depression and anxiety 
severity on PI development and predictor variables.  This builds on the dissertation study, which 
assessed the dichotomous preoperative medical history of depression and anxiety, while the 
future study will allow for prospective preoperative measurement of depression and anxiety. The 
generalized anxiety disorder 7-item (GAD-7 ) scale and the patient health questionnaire-9 (PHQ-
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9) will be used, as they are sensitive tools for the preoperative setting, are valid and reliable in 
the cardiac population and may predict cardiac mortality (Abed, Kloub, & Moser, 2014; Reynard 
et al., 2014). The hypothesis is that patients who develop PI will have statistically significant 
elevations in oxidative stress biomarkers compared to patients who do not develop PI; and 
statistically significant differences in anxiety and depression severity scores will be associated 
with levels of oxidative stress biomarkers and PI occurrence. In addition, exploring potential 
mitigating factors that led to lower than anticipated incidence in the retrospective study could 
focus on to what extent is the postoperative cardiac output of TAH-VAD patients influences PI 
prevention versus development? Although VAD-TAH patients have high preoperative comorbid 
status, implantable ventricular devices may substantially improve baseline cardiac output, 
leading to improved oxygenation, perfusion and less oxidative stress. Additionally, the PI 
prevention culture of the facility where the patients received care demonstrated a preoperative to 
postoperative continuum of preventive care which may have had a significant impact on the low 
incidence density that was reported over the eight-year study.   
Future Program of Research 
Baseline Oxidative Stress Feasibility Study 
 As described in the conceptual framework, oxidative stress plays a major role in the 
pathophysiology of PI development.  A proposed program of research would be a prospective, 
longitudinal observational feasibility study to investigate the natural history of oxidative stress 
profiles in VAD-TAH population. The primary aim will be to explore oxidative stress 
biomarkers of operating room acquired PI in adult VAD-TAH patients at VCU to determine 
feasibility for a larger study. The research will investigate biomarkers of oxidative stress by 
evaluating lipidomic markers in serum (levels of F2-Isoprostane) and urine (levels of 2,3, dinor-
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15- F2-Isoprostane and 5,6,dihydro-15- F2-Isoprostane metabolites), which are established 
markers of oxidative stress (Milne et al., 2015; Morrow, Awad, Kato, et al., 1992; Morrow et al., 
1990; Morrow, Awad, Boss, et al., 1992).  
For this study, patients will be approached in the pre-surgical clinic visit or perioperative 
unit for informed consent, baseline serum and urine samples for biomarker analysis, and 
completion of the GAD-7, PHQ-9 and demographics forms. Graduate assistants will be utilized 
to assist with patient enrollment and to transport laboratory samples. For longitudinal analysis of 
biomarkers, nine serum and urine samples will be collected using established guidelines and 
protocols from invasive lines and the Foley catheter respectively at longitudinal time points as 
described in figure 2 (Chiu, Wang, & Blumenthal, 1976; Halliwell & Lee, 2010; Il’yasova, 
Morrow, Ivanova, & Wagenknecht, 2004; Seet et al., 2011). Gas chromatography-mass 
spectrometry will be used to analyze urine and serum biomarkers under the guidance of the mass 
spectrometry core facility with expertise in biochemical-lipidomic analysis (Milne, Gao, Terry, 
Zackert, & Sanchez, 2013).  In summary, the second study would seek to understand what the 
baseline levels of lipid biomarkers to oxidative stress are in the VAD-TAH patient and describe 
any differences between those levels in patients with or without PI and any correlation with 
preoperative anxiety and depression scores. This study would be foundational in its description 
of serum and urine biomarker levels in this population and based on the findings, direct the aims 
of the third study.  
Follow-Up Oxidative Stress Study 
  The third study can enhance and expand the aims in the oxidative stress feasibility study 
while allowing for potential new discoveries. The proposed third study will be a larger biomarker 
study that builds upon findings from the second study.  In the lipidomic mass spectrometry 
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analysis of oxidative stress biomarkers, it is anticipated that significant elevations in F2-
isoprostanes and/or associated metabolites from PI during VAD-TAH intervention will be seen.  
The purpose of the second study would be to evaluate and quantify levels of these metabolites 
that are most closely associated with PI and explore alternate approaches for biomarker 
evaluation. In addition to blood serum and urine samples, for example, methods for collecting 
and analyzing exhaled breath for levels of these metabolites have proven to be highly reliable, 
accurate and feasible (Janicka, Kubica, Kot-Wasik, Kot, & Namieśnik, 2012). 
 In the event the second study failed to identify any connection between PI incidence and 
levels of isoprostanes, the third study may repeat study two by evaluating evidence of 
mitochondrial IR.  Intracellular mitochondrial approximation to elevated oxidant molecules such 
as ROS superoxides have been linked to apoptosis in animal models of skeletal IR (Tran, Tu, 
Liu, Muelleman, & Li, 2012). This could be evaluated by looking at levels of cardiolipin 
peroxidation which is directly associated with mitochondrial IR (Shen, Ye, McCain, & 
Greenberg, 2015). This would allow the current conceptual model to remain without change 
except for altering the oxidant metabolite of IR studied. 
 In summary, the goal of this developing program of research was to first describe the 
incidence and predictor variables of PI in the VAD-TAH population. From this starting point, 
progressive studies will further explore the role of PI formation as it relates to the potential 
physiologic response of the tissue and cells to IR injury following surgery through the 
identification of biomarkers associated with PI injury as it relates to oxidative stress.  Such 
biomarkers provide potential diagnostic markers of PI injury and could be further developed as a 
point of care diagnostic. Clinically, this would provide a great benefit by providing an objective 
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biomarker versus the current standard of care, visual skin assessments, which do not adequately 
reflect damage occurring in the muscle tissue. 
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